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Abstract
Proteins are of major interest for nutritional value, functionality and sensory
characteristics in foods, and biological activity as health-promoting ingredients. A large number
of potential biological activities are encrypted within the primary structures of animal and plant
proteins. This research has been based on utilizing a legume by-product, soybean meal, to obtain
value-added protein products. Forty four Arkansas grown soybean lines were subjected to
analysis for protein and amino acid (profile) content to select lines that have high protein
attributes. Three soybean lines, R95-1705 (high yielding, non-transgenic and high protein), N98445A and S03-543CR (bred for high oleic acid - monounsaturated fatty acid) were selected for
further study. Seeds from the three soybean lines were ground and defatted to prepare the meals.
The protein isolates (SPI) with highest (90-93%) purity prepared from the three meals were
hydrolyzed using a food grade enzyme, Alcalase 2.4L, under optimal hydrolysis conditions to
prepare protein hydrolysates (pools of peptides). The protein hydrolysates were tested using
simulated gastric and intestinal juices to determine the gastro-intestinal (GI) resistance of the
peptides. The GI resistant hydrolysates were fractionated to collect distinct molecular size cutoffs of <5, 5-10, 10-50 and >50kDa using ultra-filtration technique. These peptide fractions were
tested for biological activities including inhibition of ACE-I activity and cancer cell proliferation
inhibition using specific assays. Research highlights include demonstration of ACE-I activity
inhibition and cancer cell anti-proliferation activity by the GI-resistant peptides from the soybean
lines in comparison to positive controls, Captopril (anti-hypertensive drug) and Genistein (anticancer agent). A comprehensive screening provided definitive selection criteria for choosing the
10-50kDa fraction from N98-4445A for further purification to separate a single pure peptide
with enhanced biological activity. A purified peptide with a sequence of 158 amino acids and

molecular weight of 18kDa from the 10-50kDa fraction showed nearly 75 and 80% inhibition of
blood and colon cancer cells respectively. Hence, the importance of this investigation is in the
potential ability of a peptides obtained from soybean meal protein to sustain a progressive impact
on human health condition.
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CHAPTER 1
Introduction
Soybean (Glycine max) is a leguminous plant grown as a pulse crop in various parts of
the world. The pods contain seeds which are the edible parts of the plant and known for the rich
lipid and protein content. United States is the largest producer and exporter of soy in the world.
According to United States Department of Agriculture (USDA), soybeans account for about 90
percent of U.S. oilseed production. In 2014, the American Soybean Association puts the farm
production value of soybean at $40.4 billion (ASA,

Hilum

2015), and U.S exports stand at 42% of total world
trade in soybeans. The increase in soy production in
the US is due to the high yield potential of the crop
and the increase in demand for various soy products in
the globally. Genetic engineering techniques are
developed to obtain seeds with high protein, and oil

Cotyledon
Endosperm
Embryo
Seed coat
Figure 1.1. Illustration of soybean
seed parts.

content with increased economic output.

Soybeans seeds are small, round and green in color at maturity but turn yellow when they
are dried for storage. The seed parts are illustrated in Figure 1.1: a hilum (small brown spot),
seed coat (a thin layer outside that protects the seed), cotyledons (the part that stores food for the
embryo), and the embryo (that develops into a new plant). The endosperm contains various
components including carbohydrates, proteins, lipids, vitamins and minerals that are essential for
germination of the embryo. Hence, the endosperm has commercial value as soybeans are chiefly
grown for their oil which is used in various industries.
Soybean oil is widely used in the food industry and is made of five major fatty acids:
palmitic, stearic, oleic, linoleic, and linolenic. Higher percent of linolenic acid causes spoilage,
1

and rancidity in foods, which is due to hydrogenation of linolenic acid, a common practice in the
food industry employed to enhance the stability of the product. Hence, soybean breeders are
developing cultivars that consistently produce oil with lesser amount of polyunsaturated linolenic
acid, while increasing the percent of monounsaturated oleic acid.
Genotypic variations have been found to be the cause for differences, not only in the oil
content, but also in the concentration of crude protein, possibly even in the amino acid make-up.
There is an increasing demand for high oleic acid soybeans in the vegetable oil industry and the
soy meal, which is the byproduct after processing of seeds, is a source of high quality protein.
Methionine is an essential amino acid which is deficient in soybean. Hence, there is a possibility
that high oleic acid soybean meal may be containing higher amounts of amino acids, methionine
and cystine. Hence, we propose to look at the difference in the make-up of peptides between the
high protein (Hutcheson, S97-1688, R95-1705), and the high oleic acid soybean (N98-4445A)
varieties.
We know that proteins are made of amino acids and can be hydrolyzed at specific sites
with controlled digestion to yield different sized peptides. Bioactive peptides are food derived
that, in addition to the nutritional value exert a physiological effect in the body. Soybean protein
has been identified as a valuable source of bioactive peptides which can be incorporated into
foods. Preparation of peptides and their fractionation for testing their activity against disease
cells has been successfully studied by several researchers. Studies have shown that exposure to
the digestive enzymes in the stomach has an influence on the bioavailability of the peptides in
controlling the diseases (Park et al 2007, Miguel et al 2006). Since different sized fragments of
peptides would be generated by the enzymatic hydrolysis, fractionation of the GI resistant
peptides hydrolysates with definite molecular weight cut-off membranes needs investigation.
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The delivery of these peptides to the target organs is important for maximum availability
of the compound to exert its bioactivity, and controlling the spread of the disease. In vivo studies
have been conducted to test micro-encapsulation of the peptides and their bioavailability
depending on prolonged duration. There was a significant protective effect of encapsulation
against the gastric and intestinal juices and has shown a correlation between the peptide
availability and the control of the disease (Chen et al 2003). To assess the delivery system,
micro-encapsulation of these bioactive peptides using nanotechnology for food product
development and applications have been investigated (Alessa et al., 2014). The shelf-life and
sensory quality of the peptides in the food products have been tested by researchers for
developing food products (Khairallah, 2011, Alessa et al., 2014). There is increasing interest
over incorporation of bioactive peptides into foods in the Unites States. Individuals are
supplementing traditional health care products by switching to nutraceuticals and functional
foods.
Bioactive substances of food origin can be defined as components (genuine or generated)
of consumption ready food which may exert regulative activities in the human organism beyond
basic nutrition. A great diversity of food-derived bioactive substances having a non-nutrient
character can be considered as an aid in maintaining good health. Biologically active proteins
and peptides are becoming prevalent candidates for customized and unconventional treatment
strategies in disease conditions where conventional therapeutics have been proven to be
burdensome or expensive. Additionally, food products incorporated with bioactive peptides are
limited and still evolving in the United States, where there is an ever increasing need for these
products to reduce the risk of chronic diseases. Legumes like soybeans have gained much
prominence in the past few decades for their high protein value, increasing production, and
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sustained use in comparison to other food products. Research on bioactive peptides from various
sources, their generation and functional aspects have intensified over the past two decades. Pilotscale production of peptides is limited by the lack of suitable cost-effective technologies. Several
of the biological properties of legumes are attributed to physiologically active peptides in these
proteins (Korhonen and Pihlanto, 2003; Chiang et al., 2006; De Mejia and Ben, 2006). The
amino acid sequences of these peptides dictate their activities in vivo affecting cardiovascular or
endocrine or immune or nervous systems. Some of the bioactive proteins and peptides have
shown immunomodulating, antihypertensive, osteoprotective, antilipemic, opiate, antioxidative
and antimicrobial properties (Moller et al., 2008).
Heart disease and cancer are the leading causes of death in the United States. Hence,
research project designed to prepare and identify soy peptides for bioactive properties against
hypertension, a chief risk factor for cardiovascular disease (CVD), as well as various kinds of
cancers are essential. Sources like milk, other legumes and cereal grains have the potential to
provide biologically active peptides. However, factors like abundant availability, protein yield
and cost may promote soybean meal for consideration as a good source of peptides in
comparison to others. Soybean meal, a co-/by-product of soybean oil industry, is a good source
of protein (approximately 45-50%) and can be a good starting material for creating new bioactive
peptides and posing no difficulties during extraction.
The primary objective of this research was to prepare protein hydrolysates and peptides
from soy protein isolate which was extracted from soybean meal by protease digestion at
optimum degree of hydrolysis. In order for the peptides to impart their bioactivities, they need to
be resistant to the enzymatic gastro intestinal (GI) environment (Park et al 2007). Although
several broad studies confirmed bioactive peptides, assessment of gastrointestinal resistance due
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to enzymes have not been prominently assessed. Hence, gastrointestinal environment resistant
peptides were produced and tested for bioactivity. Consequently, the hydrolysates were
fractionated based on molecular size cut-offs before testing the activities against ACE-I and
cancer cell proliferation. This project provides basis for developing GI juice resistant bioactive
peptides against different ACE-I activity (potential anti-hypertension) and cancers. This was
followed by enhanced bioactivity through purification of the peptide pool to isolate single pure
peptide. Full characterization of single pure peptide(s) with highest activity was conducted using
liquid chromatography coupled with mass spectrometry (LC-MS) and matrix assisted laser
desorption ionization – time of flight (MALDI-TOF). The individual pure peptides with superior
anticancer activity was subjected to characterization and amino acid sequencing. The anticancer
and anti-ACE-I soy peptides obtained would have a wider application in supplements, food
products, and medicinal categories.
The specific objectives of this research proposal are
1. Evaluation of protein and amino acid profile of selected Arkansas grown soybean lines.
2. Extraction of protein isolate (SPI) and production of gastro-intestinal resistant protein
fractions with specific molecular sizes: 10-50Kda, 5-10Kda, and <5Kda.
3. Determination of ACE-I inhibitory properties of the GI resistant protein fractions.
4. Investigation of anticancer activities of protein fractions on human blood, breast, colon, lung,
liver and prostate cancer cell lines.
5. Separation, purification and characterization of single pure peptides for enhanced
bioactivities.
6. Mass spectrometry analysis for amino acid sequencing of single pure peptide.
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CHAPTER 2
Literature Review
Soybean production
Soybeans are one of the major oilseed crops in the United States accounting for about 90
percent of U.S. oilseed production. Large-scale production of soybeans started in the last century
in the United States as the area planted expanded rapidly. Soybeans are the second-most-planted
field crop in the country with 83.7 million acres planted in 2014 which is the highest so far
(Good, 2015). It is estimated that 30 to 40% of U.S. grown soybeans are exported (Ross, 2015).
Increased planting flexibility, steadily rising yield improvements and low production costs
favored growth of soybean acreage in the U.S. Greater than 80 percent of soybean acreage is
concentrated in the upper Midwest states in the U.S., although significant amounts are still
planted in the historically important areas of the Delta and Southeast. Stocks of soybeans are
expected to be at an eight year high this current season owing to improved management
practices, and enhanced product utility for commercialization.
The state of Arkansas ranks 10th in soybean production annually, where they are
cultivated in more than 41 of the state’s 75 counties (Arkansas Soybean Promotion Board, 2014,
Ross, 2015). Soybean production, since 1980s, has been one of the largest agricultural
enterprises in Arkansas with annual acreage of approximately 3.2 million (Ross, 2015). The crop
generates an annual revenue of $1.7 billion with an average of 48 bushels per acre (Ross, 2015).
Soybean meal is a by-product obtained after oil extraction from the seed and is a good source of
protein (Stein et al., 2008). Annually production in the U.S. is 40 Million Metric tons and
approximately 90% of it is used as a high protein component in livestock feed (Soya tech, 2015).
However, in recent years its high value protein content has gained popularity in human diets as it
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provides the basis for soy milk and vegetable protein. It is also used as a protein rich ingredient
in lieu of its functionality in food products.
Soybean seed components
Soybean is high in protein content, and 70% of the crop value is attributed to this
component. The protein content ranges between 37-42% in dry weight depending on the genetic
make-up and the crop location, while certain pure lines have up to 50% protein (Krishnan et al.,
2007). Soybean seed is composed of 8% hull, 90% cotyledons, and the 2% hypocotyls as shown
in figure 1. The cotyledons contain about 40% protein, 20% oil, 35% carbohydrate, and 5%
minerals in the form of ash.
In the seed the protein is held in discrete sites for storage, and this is estimated to be at
least 60–70% of the total seed protein. Proteins in legumes belong to the globulin family called
leguminins (11S) and vicilins (7S), or glycinin and beta-conglycinin, which account for 65%–
80% of total soy proteins (Yaklich, 2001). Several products are made from soy and its protein,
especially in the Asian cuisine and it is regarded as a healthy food ingredient. Apart from
proteins, soy contains valuable constituents like isoflavones, oligosaccharides, and germ plant
sterols, which have been studied for their health benefits.

Benefits of soy consumption
Soy product consumption has increased due to their large beneficial properties such as
being free of cholesterol, gluten, and lactose, making them suitable for allergen-intolerant
consumers and vegetarians. Soy has certain health benefits in conditions like cancers,
cardiovascular diseases, hypertension, and hormonal imbalances (Nair et al., 2002). The seeds
are the economic part of the soy plant. Key health benefits of soybeans are due to the high
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quality protein, essential fatty acids, vitamins, minerals, isoflavones, saponins, and dietary fiber
in the seeds (Perkins 1998, Ukwuru 2003, Leblanc et al 2004). Soy contains certain
phytochemicals called Isoflavones, which have potential medicinal benefits like decreasing the
symptoms of menopause, reducing the risk of certain cancers, improving bone strength, lowering
of cholesterol, and preventing kidney disorders (Leblanc et al., 2004). Soy seeds are ground to
make soy flour, which is used to prepare various food products. The use of soy in human
nutrition has increased significantly. There are numerous products on the market which are based
on soy or contain soy ingredients. Protein products for food uses include defatted flakes, grits
and flour, protein concentrate, protein isolate, and textured protein products. Soybeans can also
be used to produce whole bean products.
Soybeans are known for their high protein content and are popular among vegetarians
and the poor. They have the advantage of being a cheaper source of high quality protein and
nutritionally equivalent to animal protein. By the turn of the millennium, the popularity of soyfoods has increased among health-conscious individuals. Soy products were consumed at least
once a week in 31% of U.S. population (United Soybean Board, 2014) with retail soy-based food
industry worth $4.5 billion according to Soyfoods Association of North America (2014). Interest
in soy and soybean constituents is due to the potential health benefits in a variety of areas
including cancer, osteoporosis, and coronary heart disease (CHD) (Badger, T. M., et al., 2005,
and Wang, W. and de Mejia, E. G., 2005). Soybeans are a source of dietary peptides known for
the anti-hypertensive, anti-cholesterol, and antioxidant activities. The soy peptides also have a
major role in preventing cancers like colon, breast, prostate, and lung (Su et al., 2007,
Hernandez-Ledesma, 2009).
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Significance of soybean cultivars
Breeding newer varieties of soy is essential to produce cultivars which are resistant to
pests, tolerant to diseases, produce higher yields in terms of protein and oil, and sustain in
harsher environment. Genetic engineering techniques are extensively employed in the soybean
breeding programs in the United States ever since the introduction of the crop into the country.
There has been extensive research in the academic and industrial fields in order to produce better
quality soybean especially with high protein content, since soy protein has been a source of
amino acids which are required for human growth and development. Hutcheson line of soy,
commercially cultivated in the United States is resistant to certain viral diseases of soybean viz.,
Soybean Mosaic Virus (Wang et al., 2005). The protein content is around 38 to 40 %. R95-1705
is a breeding line with parentage that includes Hutcheson and a high protein line (~ 45 %) from
USDA. It is being grown on a trial basis for the tofu and soy sauce market (Medders, 2004).
Soybean germplasm line ‘S97-1688’ (Reg. no GP-300, PI 633736) has value as a parent because
of its competitive yield potential, higher protein content of 45- 46 %, and broad resistance to
populations of soybean cyst nematode, Heterodera glycines Ichinohe (Anand et al., 2004).
USDA and Agriculture research station at Raleigh, North Carolina developed N98-4445A, a new
soybean germplasm developed through traditional breeding methods by scientists. The oil
extracted from N98-4445A contains high levels of monounsaturated oleic acid, which is stable at
room temperatures and does not require the hydrogenation for hardening, a property useful to
prepare salad dressings, margarines, breakfast bars and baked food products (NC state soybean
producers association, 2004, available at: http://www.ncsoy.org/html/may_2004.htm). Generally,
the seeds are dried after harvesting from the field, and stored at cooler temperatures before
further processing. The oil extracted from the soybean is used for cooking food products in the
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form of vegetable oil, while the meal that remains is utilized to isolate the protein from the
carbohydrates, and other constituents. This would make the soybean meal an excellent source of
protein and carbohydrates, especially as an ingredient in cattle, equine, or poultry feed
formulations.

High oleic acid soybeans
Soybean oil consists of palmitic, stearic, oleic, linoleic, and linolenic fatty acids. Out of
these, linolenic acid (LA) is categorized under the polyunsaturated fatty acid (PUFA). It is a
major PUFA present in soybean oil, which is crucial for LDL-cholesterol lowering effect
(McKevith, 2005). Oleic acid is the monounsaturated fatty acid found abundantly in olive oil,
and is less prone to rancidity. It has a longer shelf life than linolenic acid. Around 25% of oleic
acid is present in conventional soybean oil, while linolenic acid is 7%. Although PUFAs have a
beneficial effect on the tissue nutrition, they have detrimental effect when they get rancid or
spoiled. Partial hydrogenation is used to increase stability and shelf life making soybean oil more
edible; however, this process will ultimately produce trans-fats, which act as pro-oxidants and
become carcinogenic when consumed by the human beings. Oleic acid does not show these
effects and hence, studies of producing higher amount of oleic acid have been undertaken.
Genetic modification of soybeans to produce high oleic acid in the seeds is done by
incorporating the gene into a bacterial cell and its transformation into the plant cells by
recombination and DNA cloning techniques (Australia New Zealand food authority, 2001).
Desaturase enzyme is required for the synthesis of linolenic acid in soy. Insertion of a second
copy of the desaturase gene causes gene silencing, where both copies of the fatty acid desaturase
gene are switched-off, and prevent the synthesis of linolenic acid. Due to lowered linolenic acid
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production, the oleic acid accumulates in the developing soybean seed. Soybean bred to have low
levels of linolenic acid would be replaced by higher quantities of oleic acid. Hence, soybean oil
that is extracted from these seeds is less likely to deteriorate or go rancid, and therefore does not
need to be hydrogenated. Researchers in the academic institutions, public and private soybean
breeders in the United States released soybean varieties with as low as 1% linolenic acid
(Australia New Zealand food authority, 2001). Soybean breeders are working on mid-to higholeic acid soybean varieties with genetic modifications to develop cultivars that consistently
produce an oil with greater than 50% oleic acid, called mid-oleic, and hope to combine the
elevated oleic acid trait into their varieties with 1% linolenic acid that are grown commercially in
the Midwest.

Proximate composition of Soybean flour and meal
Soybeans contain about 40% protein and are used in foods, livestock feed, and oil
production, and are a source of other healthcare products, such as sterols and vitamin E. Since,
soy protein contains almost all the amino acids that are essential to human nutrition; it is a great
substitute for animal protein. Removal of the lipid content is the first step in preparing for
extraction of proteins from the flour. Defatted soy flour contains 17% soluble and 20% insoluble
carbohydrates and is an abundant and relatively inexpensive source of proteins (Perkins, 1998).
The oil is removed from the soy seeds by extrusion method, or by solvent extraction. The
soybean meal is collected to extract the protein. Solvent extraction is the most common
procedure in the U.S. for separation of lipid from soybean flour. It is 100% extraction-efficient,
and is suitable for handling large volumes of soybeans (Bargale et al., 1999).
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The composition of a typical solvent-extracted soybean-meal is given in Table 2.1. Soybeans
from the northern and western soybean growing states contained 1.5-2% less protein and 0.20.5% more oil than soybeans from southern states due to the environmental impact on the yield
(Grieshop et al., 2003).
Tables 2.1. Composition and nutrient content of 100 g soy flour (USDA, 1986).
Type
Moisture Protein
Carbohydrate CrudeFiber Calcium Iron
Fat (g)
(g)
(Nx5.71)
(g)
(g)
(mg)
(mg)
47.0
1.2
38.4
4.3
241
9.24
Defatted 7.3
34.5
20.6
35.2
4.7
206
6.37
Full fat 5.2
Type
Zinc
Thiamin Riboflavin
Vitamin B6 Folacin Sodium
Niacin (mg)
(mg)
(mg)
(mg)
(mg)
(mcg)
(mg)
0.70
0.25
2.61
0.57
305.4
20
Defatted 2.46
0.58
1.16
4.32
0.46
345.0
13
Full fat 3.92

Mechanical oil expression is another method with an extraction efficiency of around 70%
and supplies to a specific niche market (Bargale et al., 1999). Improvement in the economics of
mechanical oil extraction rate can make it viable on a large scale in the soybean industry in the
United States. The defatting techniques of soy protein isolates can modify their functionality. Nhexane has been used extensively in soy processing to remove fat from the soy flour. Other
alternative techniques such as non-alcoholic aqueous extractions have also more recently studied
(L’hocine et al., 2006). Improvement in processing and functional characteristics has resulted in
an ever-increasing demand for soy protein ingredients from soybean meal.
Soy meal is a byproduct of soy oil industry and is the raw material for extracting soy
protein. Research in alternate fuels and the advent of bio-diesel, a product that needs soy oil for
preparation, leads to increased production of soybean meal. Since, being a byproduct, it is a less
expensive source for producing proteins rich in essential amino acids. Soybeans from the
northern and western soybean growing states contained 1.5-2% less protein and 0.2-0.5% more
oil than soybeans from southern states (Grieshop et al., 2003). The study also showed that crude
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protein concentrations of soybean meals samples collected from the southern U.S. maturity zones
were higher than those collected from the northern maturity zones. The results from a study on
the variations in protein and oil content in soy also prompted environmental growth conditions to
influence the protein concentrations (Hurburgh et al., 1990), where, U.S. grown soybeans
showed consistent state and regional differences.
Soy protein concentrates are available in different forms; granules, flour and spray dried.
Because they are very digestible, they are well-suited for children, pregnant and lactating women
and the elderly. Most fiber of the original soybean is retained in the soy protein concentrate and
is widely used as functional or nutritional ingredient in a wide variety of food products. Soy
protein concentrate (SPC) is about 70% soy protein and is basically soybean without the water
soluble carbohydrates, which are removed from de-hulled and defatted soybeans. SPC is used in
meat and poultry products to increase water and fat retention. Due to the presence of high
protein content, it is used in infant foods to improve nutritional values with more protein, and
less fat. They are also used in pet foods, milk-replacers for calves, pigs, and even used for some
non-food applications.
Soy protein is also present as an isolate where it is separated from the low molecular
weight polysaccharides present in the flour. Soy protein isolate (SPI) is prepared by chemical or
enzymatic hydrolysis of the soy protein (Morita and Kiriyama, 1993, Shih and Daigle 2000,
Paraman et al., 2006). The alkaline hydrolysis involves solubulizing the protein in water by
increasing the pH to a range of 8 to10. The insoluble starch is separated by centrifugation and the
protein is precipitated by bringing the suspension to iso-electric pH of 4.5. Alpha-amylase is
used to digest the starch and separate the protein from the soy flour in suspension in the
enzymatic hydrolysis method.
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Soy protein has been studied for the significant health benefiting activity in human beings
in controlling diseases like hypertension, and heart disease. More than performing different
metabolic and regulatory functions, proteins from food sources have been identified to be
antagonists for many disease states like cancer, hypertension, oxidative stress, inflammation, and
diabetes (Meyers et al., 2003, Kim et al., 2004, Nam et al., 2005). The protein is broken down
into peptides by enzymatic methods. In general, naturally occurring peptides are classified based
on the function they perform. Some are classified as signal transduction components, others gene
regulators, while some others serve as components mediating metabolism, translation, folding
and degradation (Monowar et al 2004).

Amino acid analysis of proteins
The composition of amino acids in proteins can be determined by complete hydrolysis of
the protein into its amino acid residues. The most common method is by acid hydrolysis
followed by performic acid oxidation for cysteic acid and methionine sulphone. Alkaline
hydrolysis can be sued to determine the amount of tryptophan, an essential amino acid, in the
protein. However, significant destruction of amino acids occurs during acid hydrolysis of protein
from in food material which is more evident with the essential amino acids: methionine, cystine,
lysine, threonine, and tryptophan. Specific hydrolytic techniques would need to be carried out for
different foodstuffs as their proteins differ widely in amino acid compositions. Amino acids are
released and destroyed at different rates that depend upon the amino acid composition and
characteristics of the proteins in the sample.
Chromatographic techniques including High Pressure Liquid Chromatography (HPLC)
and Gas-liquid chromatography are used for detection of amino acids and their quantification.
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Pre-column derivatization with Dansyl chloride (5-dimethylamino-1-naphthalene sulphonyl
chloride) is required which produces fluorescent dansyl derivatives that can be separated by a
reversed phase column chromatography. Ion exchange chromatographic separation of peptides
has been demonstrated to be more effective when followed with HPLC that uses various nonpolar stationary phases, for separation of non-polar amino acid derivatives (Molnar and Horvath,
1977).

Preparation and bioactivity of peptides from various food sources
Soy protein contains all the essential amino acids, and hence is a good source of bioactive
peptides when exposed to hydrolysis by the gastro-intestinal enzymes. A thorough understanding
of the soy protein and its derivatives is possible when we digest them with the endoproteases, to
produce the short chain peptide fragments, and evaluate them for the functionality. It is also
important to discover new peptides with health benefits in soy-hydrolysates. The identification of
novel bioactive compounds will contribute towards the development of functional foods that can
be used to enhance health and quality of life.
Proteins are made of amino acids, while peptides are chains of amino acids cleaved-out
from the main protein molecule. They may have amino acids ranging from 3 or 4 to over 50
amino acids. Enzymatic hydrolysis, digestion in the gut, and food fermentation are the three
methods in which protein fragments or short amino acid chains are produced. Peptides might
occur naturally in foods, can be the products of human digestion, or can be obtained in the lab
through enzymatic hydrolysis. Controlled hydrolysis of the soy protein has the advantage of
producing peptides with certain number of amino acids that will enhance their functionality.

15

Figure 2.1. Breakdown of proteins into peptides and amino acids by enzyme
hydrolysis (Sugano, 2006).
Proteins like whey, casein, soy, and those obtained from certain fruits and vegetables are
known to lower disease progression due to their bioactivity. Many of these are subjected to
proteolysis to yield peptides in various size ranges. These are called dietary peptides which also
exhibit functional properties like the proteins (Figure 2.1). Foods like cereals, milk, vegetables
and fruits also contain many bioactive proteins/peptides present in their tissues and have
different functions (Korhonen et al., 2003, Antonio, 2003). Food-derived bioactive peptides from
dietary proteins commonly contain 2–9 amino acids, which may be extended to 20 or more
amino acid units (Kitts D. D, and Weiler K., 2003). The food industry has shifted towards using
biologically active proteins and peptides, while food researchers are considering different
bioactive substances of food origin as health enhancing ingredients for use in foods commonly
referred to as functional foods or nutraceuticals (Mine Y, and Shahidi F., 2006, and Shimizu and
Dong Ok Son, 2007). Food producers can make health claims about their products if they can
produce sufficient scientific evidence.
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The research on bioactive proteins and peptides has some common objectives like,
providing evidence, and giving human-study basis for the reduction of disease risk claims on the
labels, scientific design for proving the persistent effect of the food or pharmaceutical
preparation, and evaluating the risks of consumption, including allergic potential. Regarding the
discovery of novel peptide drugs, the chemical properties of food-derived peptides and proteins
can be readily modified in systematic ways for drug design and development. Small changes in
the structure can lead to dramatic changes in bioactive potency and function, and these peptides
are generally less toxic than other organic 'natural molecules'. Future research should focus on
establishing novel production technologies and understanding the interaction of different
bioactive proteins and peptides with multiple components during production and within a
complex food of an overall diet. There are many unknown factors regarding to physicochemical
and biological interactions of bioactive ingredients, which may result in inactivation or in
synergisms and antagonisms. Understanding the mechanisms of possible interactions is
important to develop an adequate packaging system, like micro-encapsulation, to enable the
improved delivery and protection of bioactive ingredients. Research continues to discover novel
bioactive proteins /peptides, functions and health benefits - all of which reveal the striking
potential for natural selection through evolution to produce food molecules that act beyond
simply providing nutrients. Discovering these benefits and potential applications remains a great
challenge for both nutrition research and pharmaceutical design.
The processing of protein into peptides in the GI tract greatly increases their healthful
effects by exposing active groups within the amino acid chain. Soy peptides in recent studies
have shown in to be most promising anticancer agents. Found in major readily-available foods in
the market, these peptides are an accessible component to healthy living. In 1999, the Food and
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Drug Administration approved a health claim for the cholesterol-lowering properties of soy
protein (Pena-Ramos E. A., and Xiong Y. L., 2002) and soybeans are known to contain several
bioactive components (Kim S. E. et al., 2000). Proteins in soybean have hypo-cholesterolemic,
anti-atherogenic, and body fat reducing properties, while the soy peptides also reduce body fat,
and are readily absorbed into the blood (Michihiro Sugano, 2006). As more results are reported
on the biological activities of such proteins, little is known about the mechanism by which
proteins exert these functions, or the basis for each protein to function so uniquely. To
understand better a study is required on peptides that these proteins breakdown into when
digested with proteases. Such a study would help in determining what portions of the protein
constitute the functional aspect. Soy peptides are known for their bioactivity in the organ tissues
and protect the body from diseases like cancers, tumors, mutations, and high blood pressure.
Recent advances in science have brought various techniques of analyzing the beneficial effects
of the soy peptides, and to determine their amino acid sequence. These peptides would be
synthetically produced and incorporated into foods to deliver the health benefits.
The bioactive peptides produced by soybeans possess diverse and unique health benefits.
These can be effective in the prevention of age-related chronic disorders, such as cardiovascular
disease, cancer, obesity, and decreased immune function. Bioactive peptides are released from
dietary proteins by either gastrointestinal digestion or by the processing of foods. It is known that
during gastrointestinal digestion or food processing, these peptides are released from the parent
protein and act as regulatory compounds with hormone-like activities (Korhonen H, and
Pihlanto, 2003). Microbial fermentation is an efficient way to produce bioactive peptides which
can be released by the action of enzymes derived from microorganisms (Korhonen H, and
Pihlanto A., 2003). Interest in bioactivity of fermented soy protein rich products including milk,
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natto, tempeh, soy sauce, soy paste has grown in recent years (Wagar et al., 2009, Rho et al.,
2009, Kwon et al., 2010). Tryptic hydrolysates of soy protein produce immuno-modulatory
peptides. Kitts and Weiler (2003) showed that these peptides stimulate super-oxide anions, which
trigger nonspecific immune defense systems. Evidence suggests that these peptides are absorbed
by the gastrointestinal system, and exert their action on specific target organs in humans.
Research and clinical trials have demonstrated the biological activities of peptides, but the
specific mechanism of action requires further investigation.
Research in bioactive compounds from foods that provide nutrition and health benefits
since the late eighties have opened new frontiers in the field of food and nutrition (Mine Y, and
Shahidi F., 2006). These substances, which are both nutrient and non-nutrient, produce
regulatory effect in the organ tissues of the human body, particularly to control a disease or to
elicit a specific physiological function. Many bioactive peptides are inactive, and require
enzymatic proteolysis for release from their protein precursors. Once activated, these biopeptides exert activities such as ACE-Inhibitory, immuno-modulatory, antimicrobial, mineral
binding, and anti-mutagenicity.
Shimizu and Dong Ok Son (2007) studied the effect of food-derived peptides and their
intestinal functions while getting hydrolyzed by digestive enzymes in the intestinal tract. The
absorption of the peptides intact is important for their action in their target organs, while the
intestine-modulatory peptides can express their functions in modulating the intestinal epithelial
cell functions. These peptides are studied to cause prevention of certain intestinal diseases.
Certain peptides showed cytotoxicity which leads towards a cancer protective effect that could
exist for such bioactive peptides (Hartmann R. et al., 2007).
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Antihypertensive activity and sources
Heart disease is number one cause of diseases-related deaths in the United States and it
affects both children and adult population (Mozaffarian et al., 2014). According to the American
Heart Association and the Center for Disease Control and Prevention 610,000 people die of
heart-related diseases in the U.S (CDC, 2015). Hypertension is a major risk factor for coronary
heart disease and the most important factor for stroke related deaths (National Heart, Lung and
Blood Institute, 2014). Individuals less than 50 years old are prone to increased cardiovascular
risk due to elevated blood pressure. Increase in blood pressure is known to be significant due to
aging, but diet and other environmental factors cause hypersensitivity due to alterations in
biochemical pathways.
Proteins from foods have been shown to possess anti-disease properties (Mine and
Shahidi, 2006). Most bioactive peptides are antihypertensive and show their activity by
inhibiting angiotensin-I converting enzyme (ACE-I). ACE-I belongs to a nonspecific dipeptidylcarboxypeptidase group of enzymes which is associated with the regulation of blood pressure. It
modulates the rennin-angiotensin system by converting the decapeptide angiotensin I into
angiotensin II, a potent vasoconstricting octapeptide. This leads to an increase in blood pressure,
and hence, inhibition of the ACE-I will result in an antihypertensive effect (Shin Z. I. et al.,
2001). Research found ACE-I inhibitory bioactive peptides in soy-protein enzyme hydrolyzates.
In vivo experiments on ‘spontaneously-hypertensive’ rats had lowered blood pressure when the
peptide fractions were administered orally. Alcalase digests of soy protein also produced
antihypertensive peptides in the same experiment (Wu J., and Ding X., 2001). There was a
significant (P<0.05) decrease in systolic blood pressure in the rats when oral doses of these
peptides were given in a dose-dependent manner. However, higher doses (1000 mg/kg of body
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weight/day) did not produce any effect on the blood pressure of normo-tensive rats. Fermented
soybean products are a good source of ACE-I inhibitory bioactive peptides. Research found that
traditional Asian fermented soy foods, such as soybean paste (His-His-Leu), soy sauce, natto,
tempeh, and chunggugjang, a traditional fermented Korean soybean product have ACE-I
inhibitory peptides (Okamoto A. et al 1995, Gibbs B. F. et al 2004, Potter S. M., 1995, Korhonen
H, and Pihlanto, 2003).
Healthier and natural ACE-I inhibitory peptides can be prepared from daily dietary food
proteins. These novel functional food additives will replace the expensive and health diminutive
ACE-I inhibitor drugs. Anti-ACE-I activity of has been investigated in casein (Maruyama et al
1985), fish muscle (Kohama et al 1998), soy sauce (Okamoto et al 1995), and rapeseed (Marczak
et al 2003), from the respective peptides either in vitro or in vivo. Potter, in 1995, reported that
hyperlidemic or hypercholesterolomic lesions that cause arteriosclerosis and hypertension are
preventable by consumption of soybean protein. Fermented products like soybean paste (Ahm et
al 2000) and soybean hydrolysate (Yu et al 1996) were shown to have exerted an inhibitory
activity on ACE-I in vascular tissue in vivo. Four ACE-I inhibitory peptides isolated from the
peptic digests of proteolysis of glycinin were engineered using varied proteases to harness
peptides that exhibit ACE-I inhibitory activity. Accordingly, the Protease P hydrolysate
contained a suite of very potent ACE-I inhibitory peptides that were subsequently fractionated
and purified. A significant fraction of the ACE-I inhibitory activity could be ascribed to a
pentapeptide, Val-Leu-Ile-Val-Pro (VLIVP). Considering the diversity and complexity of the
different protein types of soybean, soy protein provides an abundant source of biologically active
peptides. Many potential antihypertensive peptide sequences are embedded in the available
protein sequence data for glycinin, the major storage protein and 11S globulin of soybean. This
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potential is yet to be realized. There exists therefore a great potential for releasing these bioactive
peptides from their latency using proteases of varied specificity. In the present investigation,
proteolysis of glycinin was engineered using varied proteases to harness peptides that exhibit
ACE-I inhibitory activity.
There have been reports on antihypertensive food peptides with bioactivity other than
ACE-I inhibition. These peptides were found to possess antioxidant, vasodilator, and opioid
activities (Yoshikawa et al 1994, Fujita et al 1996, Sipola et al 2002, and Kuono et al 2005).
Peptides derived from egg-white, and their synthetic analogues exerted non-ACE-I-mediated
vasodilator effects in controlling hypertension (Fujita et al., 2000). In other studies, pepsin
hydrolyzed egg white inhibited ACE-I in Vitro and exhibited antihypertensive effects in
spontaneously hypertensive rats in vivo (Miguel et al 2006). Peptides from egg whites
significantly reduced the vascular resistance and produced blood-pressure-lowering effects in
hypertensive rats, independent of ACE-I inhibition (Fujita et al 2000). Although more studies are
necessary to clarify the mechanisms responsible for the antihypertensive and vasodilator
properties of these sequences, our findings provide new evidence for the potential of egg-white
peptides as functional food ingredients with therapeutic benefits in the prevention and treatment
of hypertension and other associated disorders. The ACE-I inhibition has a major role in antihypertensive activity resulting in reduction of heart disease; the peptides exerting such
bioactivity are favorable for production either by enzyme hydrolysis of protein isolates or
artificial synthesis. The bioactive peptides have varied activity depending on the organ tissue in
to which they are exposed. Hence, these peptides can be studied for additional bioactivity and
health promotion, since research supports such a possibility. Various sources of bioactive
peptides and their activities are listed in Table 2.2.
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Table 2.2. List of proteins and their products with anti-ACE-I activities.
Anti-ACE-I agent

Source

Reference

Peptide fractions

Fish (Tuna)

Lee et al., 2010

Peptides

Spinach

Yang et al., 2003

Peptide

Tuna muscle

Qian et al., 2007

Peptide fractions

Yogurt

Donkor et al., 2007

Peptides

Hydrolyzed corn gluten

Yang et al., 2007

Protein Hydrolysates

Pipe fish (Syngnathus
schlegeli) muscle protein
Casein

Wijesekara et al., 2011

Proteins

Maruyama et al., 1987

Various cancers and anti-carcinogenic compounds.
Colon cancer
Colon cancer or colorectal cancer is the third most common cancer and the third leading
cause of cancer related mortality in the United States (American cancer society, 2015). Eleven
percent of total cancer deaths are due to colorectal cancer, especially in men who are 50 years
and beyond. It has relatively low incidence in women. Most colon cancers develop as a tissue
growth into the center of the colon or the rectum called Polyps. Certain types of polyps normally
tend to become cancerous and are called adenomas. Ninety five percent of colorectal cancers are
adenocarcinomas. Evidence shows that dietary components are the major factors in the cause of
the colorectal cancer. Animal fat, red meats, chocolate, alcohol and refined cereals are the foods
that have been identified to promote high incidence of colorectal cancers in the Western societies
(Sandler RS, 1996, Potter JD, 1996, Levi et al., 1999). Number of clinical and epidemiological
studies provide clues that these food compounds may act as suitable markers or dietary
determinants that when modified and prepared in a bio-functional form can serve as bioactive
compounds in reducing the incidence of colorectal cancers (Cancer statistics, 2004)., whereas
fruits, vegetables, fiber, whole grains and their compounds like folate and calcium have been
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identified as protective agents against not only colorectal but also other cancers (Levi et al.,
1999). Apoptosis is found to be the best natural defense against cancer. The molecule, P53
induces apoptosis in some cell types when over-expressed, and is in fact considered invaluable to
induce apoptosis in states of DNA damage (Sherr, 1996). The P53-induced apoptosis activity is
common since P53 can either activate death genes like the Bax, or suppress survival genes like
the Bcl-2 (Miyashita et al., 1994). Both these are considered molecular markers to detect
apoptosis.
Breast cancer
Generally, most breast cancers originate in the ducts (ductal carcinoma) while others are
found in lobules (lobular carcinoma) or in other parts of the breast tissue. The common form of
breast cancer is the invasive ductal carcinoma that develops and penetrates the duct wall before
invading the fatty tissue of the breast before spreading to other parts of the body. According to
American Cancer Society invasive type of breast cancer accounts for about 80% (DeSantis,
2013). It is the second leading cause of cancer-related death in women and over 3 million women
have been treated in the U. S. so far for breast cancer (Siegel, 2014).
Lung Cancer
Lung cancer develops along the lining of the bronchi, and with time, causes precancerous
changes within the lung. It is the most leading cause of cancer death in men and women in the
United States due to the habit of cigarette smoking among the population (American Cancer
Society, 2015). Formation of chemicals for new blood vessels allows for tumor formation and
denotes true cancer development. At an advanced stage the cancer cells break away and spread to
other tissues, which is called metastasis and 85% of all lung cancers are non-small cell type
(American Cancer Society, 2015). According to the American Cancer Society (2015) other
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classifications of lung cancers include squamous cell carcinoma, adenocarcinoma, and large-cell
undifferentiated carcinoma. For the year 2015, it is estimated that 221,200 new cases of lung
cancer (both small cell and non-small cell) will be diagnosed and 158,000 deaths are predicted.
Liver cancer
Liver cancer is the leading cause of cancer related deaths in the world but it is less
common in the United States among major cancers discussed here (American Cancer Society,
2015) with 35,660 new cases that are expected to be diagnosed and 24,550 deaths are predicted
in 2015. It is more common in men than in women and is caused by mutations in the liver cells
resulting in several types of malignant (cancerous) and benign (non-cancerous) tumors.
However, benign tumors, most common type is hemangiomas, do not grow into nearby tissues or
spread to distant parts of the body. Hepatocellular carcinoma is the most common type which
forms cancer nodules in the liver and is the most common type seen in the U. S.
Prostate Cancer
Prostate cancers start developing in the prostate gland with very small morphological
changes occurring to the gland cells. This type of cancer is also called adenocarcinoma. The
changes that occur are called prostatic intraepithelial neoplasia (PIN) that can be either lowgrade or high-grade. A large number of cancerous cell proliferations are expected in the case of
high-grade differentiation (American cancer society, 2006). Prostate cancer is the most common
non-skin cancer in the United States. It is the second most cause of cancer death in men, first
being lung cancer. The American Cancer Society has predicted approximately 220,800 new
cases and 27,540 deaths due to prostate cancer in 2015 in the Unites States (American cancer
society, 2015). There is not much involvement of food proteins or peptides with prostate cancer
research as yet, as they do with other cancers.
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Blood cancer
Unregulated proliferation of abnormal blood cells are characterized as a group of diseases
called blood cancers. The disease affects the production and function of blood cells in the bone
marrow, which is the site for stem cells that mature and develop into three types of blood cells:
red blood cells, white blood cells, or platelets. In most blood cancers the abnormal or cancerous
cells prevent blood from performing many functions, including fighting infections or preventing
serious bleeding. According to American Society of Hematology there are three major kinds of
blood cancers:
1. Leukemia is caused by the rapid production of abnormal white blood cells which impairs
the bone marrow to produce red blood cells and platelets and reduces the ability to fight
infections.
2. Lymphoma affects the lymphatic system, which removes excess fluids from the body and
produces immune cells. Abnormal lymphocytes become lymphoma cells, which multiply
and collect in the lymph nodes and other tissues thereby disrupting the immune system.
3. Myeloma affects the plasma cells which are white blood cells that produce disease- and
infection-fighting antibodies.
The American cancer society estimates 54,270 new cases of leukemia in 2015 and 24,450
deaths are expected due to the disease in the United States. The leukemia’s are classified into
four main groups according to cell type and rate of growth: acute lymphocytic (ALL), chronic
lymphocytic (CLL), acute myeloid (AML), and chronic myeloid (CML). Chemotherapy is the
only treatment for blood cancers and the expected survival ranges between 25% (AML) to 84%
(CLL) depending on the cancer state and disease progression.
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Control of cancer using food components
Researchers have hypothesized several mechanisms of action using specialty compounds
in mitigating breast cancer. Aiding chemoprevention using vitamins and other compounds to
reduce the risk of developing cancer, block or suppress malignant transformations or disease
progressions has gained considerable attention in the recent years. Some of the possible biochemical mechanisms include apoptosis, arresting cell cycle progression, and also interfering
with metabolism. Several food products are known to contain biomolecules that aid in alleviating
the disease progression by preventing cancerous cell proliferation. Agricultural products
including fruits and vegetables are considered good sources of anti-cancerous/anti-proliferative
agents (Hocman G, 1989). For example, breast cancer cell lines when tested with the juice
extracts of Brassica family exhibited anti-proliferative effects signifying the presence of
constituents within the vegetables can prevent cancer progression (Brandi et al, 2005). Proper
modification and application of these products can replace costly drugs or other invasive
treatments of cancer.
There are several compounds documented and thought of as being able to delay or reduce
cancer progression. Tricin, for example, present in rice bran is a flavone that is shown to cease
colon cancer cell proliferation. Furthermore, it inhibited cycloxygenase activity, reduced
prostaglandin production and thus interferes in intestinal carcinogenesis in mice (Cai et al.,
2005). Certain chemo-preventive phenols obtained from brown rice were shown to inhibit
growth of both colon and breast cancer cells. Most of the functions that rice bran elicits are
attributed to its non-protein components. However, recent studies have shown that a peptide
derived from rice bran to possess activity against cancer (Kannan et al., 2010, Li et al., 2014a
and 2014b), Alzheimer’s and obesity (Kannan et al., 2012). The newly discovered soybean

27

peptide lunasin is shown to be an anticancer agent even though evidence of an effect of soy
peptides on oncogenesis still requires groundwork (Kobayashi H. et al., 2004). Suppression of
ovarian cancer cell invasion by blocking urokinase upregulation was attributed to Kunitz trypsin
inhibitor, a soy peptide with anticancer properties in their study by Xiao R. et al (2005). Papain
catalysis of Tuna dark muscle by-products resulted in a 12 amino acid peptide that showed
anticancer effect (Hsu et al., 2011). Kim S. E et al (2000) studied the inhibition of tumorgenesis
by a soy protein isolate diet due to enhanced production of somatostatin which caused antiproliferation effect. Several low and high molecular weight peptides derived from giant squid
(Dosidicus gigas) using proteolysis have been demonstrated to show cytotoxicity against MCF-7
human breast cancer cells (Aleman et al., 2011). Peptides from other seafood sources including
shrimp and snow crab proved to be sources of peptides with anticancer activities (Doyen et al.,
2011, Kannan et al., 2011). Peptides obtained by thermolase hydrolysis of defatted soy protein,
further purified with ethanol and fractionated by gel filtration chromatography, showed an in
vitro cytotoxicity on mouse monocyte macrophage cell line. At 1 mg/mL, this fraction
significantly affected cell cycle progression by arresting the cells in G2/M phases. Purification of
these peptides with C18 HPLC resulted in 1157 Da nonapeptide (X-Met-Leu-Pro-Ser-Tyr-SerPro-Tyr) (González de Mejía E. et al., 2004).
A protein in blood with a tripeptide sequence (Arg-Gly-Asp) is commonly known to bind
and exert biological functions like interference with cancer cell cycle progression (Yang et al,
2006). Peptides containing this particular sequence demonstrated positive anticancer activity by
inhibiting tumor growth formation, induced apoptosis and cell cycle (G1 phase) arrest in breast
cancer cell lines (Yang et al, 2006). A plant protein, calcaelin isolated from the mushroom
Calvatia caelata was found to reduce breast cancer cell viability and progression (Ng et al,
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2003). The differences in protein expressions during healthy and cancer state have been utilized
by studies to identify and monitor these marker proteins for cancerous states to determine the
disease progression (Roberts et al, 2004). A few of them include estrogen receptor-alpha, betacaesin, bax, and cytokeratin 7.
Food sources have been studied for reducing lung cancer by deriving compounds that
affect the cancer cell apoptosis and biochemical pathways that can lead to tumor stasis. Studies
have found an association between consumption of large quantities of fish and a decreased rate
of lung cancer (Takezaki et al, 2001). Certain chemical compounds, called cumestrans, present in
green vegetables have been shown to suppress lung cancer disease states (Schabath et al., 2005).
Isoflavones present in a wide variety of food products including soybeans, yams and chickpeas
are common anticancer agents in reducing the rate of lung cancer (Shimazu et al., 2010). Certain
proteins are also known to elicit anticancerous and apoptotic roles. Researchers have
demonstrated apoptotic properties of milk on transformed cell lines where the protein responsible
was identified as a multimeric form of alpha-lactalbumin (Hakansson et al, 1995). The lung
cancer cells (A549) exhibited characteristic features of apoptosis while their viability was
reduced by 98%. Animals fed with protein rich diets (casein) showed reduced pulmonary
metastatic disease and tumor weight in other studies (Mahaffey et al, 1987).
Certain nutrients that are found in natural foods have been shown to reduce the incidence
of developing prostate cancer, and also help slow down the disease progression. Again the
nutrients present in fruits and vegetables serve important roles in mitigating prostate cancer. Of
the many compounds present in fruits and vegetables, lycopene has been long considered to be
an excellent fighter against prostate cancer. Lycopene is present in tomatoes, papaya, grapefruit,
watermelons, and guava. The action of lycopene is attributed to its ability to scavenge free
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radicals and serve as a powerful antioxidant (Hwang et al., 2005). It has been shown that
antioxidants slow cancer progression even at the stage when tumors are clinically detectable
(Borek, 2004). Soy proteins have been studied to cause a possible reduction in the prostate
cancer disease progression. With soy proteins it is only a possibility that they may inhibit
prostate cancer since they affect tumor cell apoptosis and not inhibition of cancer cell
proliferation. (Bylund et al., 2000).
Chief compounds that are known to arrest prostate cancer cell proliferation are the
flavones/isoflavones, soy proteins, substances like sulforaphane present in cruciferous
vegetables. Bowman Birk inhibitor (BBI), a soy protein component, has been shown to suppress
carcinogenesis in human prostate cancer cells and has also been the subject of promising clinical
trials in cancer patients (Meyskens 2001, and Badger et al 2005). Large studies have shown that
consuming at least two servings of tomato sauce per week confers a significantly lower risk of
developing organ-confined prostate cancer, locally advanced disease, and metastatic disease
(Bowen et al., 2002, Giovannucci, 2002). Sulforaphane, a compound found in cruciferous
vegetables such as broccoli and cauliflower, helps the body to repair the damage caused by
cancer-causing substances, thereby helping to slow the cancer growth process (Myzak et al.,
2005). Isoflavones have been shown to influence the production, metabolism, and excretion of
testosterone and estrogens, hormones that can play important roles in the development and
spread of prostate cancer (Dillingham et al., 2005). Increased consumption of soy products or
isoflavones has shown some effect on slowing the rate of prostate specific antigen (PSA) rise in
several studies, but not all patients responded in the same manner and the results have been
inconclusive (Davis et al., 2000).

30

Spinach flavonoids possessing antioxidant properties are known to cause
chemoprevention of PCA using human PC3 cells. They are also known to have anti-proliferative,
and anti-inflammatory properties. Flavonoids were found to arrest cell-cycle G1 phase, and cellcycle prolongation that could possibly mediate the growth arrest of prostate cancer cells (Bakshi
et al., 2004). Peptides derived from spinach have also shown significant biological activities in
human cell lines (Yang et al., 2003). Another example of action of flavonoids originates from
grape seed extract. Studies have shown that grape seed extract inhibits cancer cell proliferation
and induces apoptosis of the same in nude mice (Agarwal et al., 2002). Mechanism of action
points to markers involved in the apoptotic signaling pathway. Markers like caspases were
broken down upon treatment of cells with grape seed extract. The study concluded that the
flavonoids from grape seed extract activated certain caspases and induces caspase mediated
apoptosis (Agarwal et al., 2002).
Role of proteins and peptides against cancer
Proteins and peptides have been shown to affect anti-proliferative effects on colon cancer
cells, and these have been confirmed with animal studies. Predominantly flavones and
isoflavones have been shown to possess anti-proliferative/anticancer effects on colon cancer cell
lines. Cereals like rice or rice bran for example, has proteins, and other important components
that inhibit cancerous cell proliferation (Kannan et al., 2008, 2009, Li et al., 2014). Amino acids
may play an indirect role in impeding cancer induction. Many protein diets including soy protein
contain non-essential amino acids that promote glucagon production. This in turn down regulates
the activity of insulin and, produces IGF-1 (insulin like growth factor-1) antagonists.
Additionally, the presence of low levels of essential amino acids in many diets (vegan diets) may
decrease hepatic IGF-1 synthesis. This causes a negative effect in cancer formation. Hence these
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diets when void of excess fat may prove protective against prostate, breast and also colon cancers
that are linked to insulin resistance (McCarty et al., 1999).
Although genetic factors are associated with the etiology of the disease and that they
predispose individuals to colorectal cancer, much of this predisposition appears to be related to
differences in dietary habits (Potter JD 1996). A number of in vitro studies suggest that proteins
may be protective against colorectal and many other cancers. For example the whey protein has
been proven to reduce the incidence of tumor formation in rats that were chemically induced to
have colon cancer (Hakkak et al., 2001). The same study compared the effect of casein protein as
diet to that of whey protein in decreasing the tumor formation, and found that casein did not
prove as effective in reducing the tumor formation. Also whey proteins have been shown to
protect more effectively than red meat against chemically induced formation of aberrant crypt
foci that are considered as markers for colon cancer, first detected in rodents in 1987 (Bird RP,
1987) and in Wistar rats (Belobrajdic et al., 2003). Other proteins investigated for anticarcinogenic properties of the colon include alpha-lactalbumin. Studies demonstrated cell growth
during the initial 3 to 4 days at low concentrations of the protein alpha-lactalbumin (10-25
ug/mL). After the fourth day, cell proliferation had ceased with low viable cell counts suggesting
probably a delayed apoptotic behavior (Sternhagen et al., 2001).
Proteomics has greatly aided in the study of mechanisms of actions of several food
components. Some of them include psychoactive compounds present in grape seed extract (Kim
et al., 2006), and anti-microbial peptides from cheese extracts (Losito et al., 2006). Molecular
targets on which these dietary components act have been elucidated using the colon cancer cells
as a model with the help of proteomic techniques like the 2-dimensional gel electrophoresis, and
mass spectrometry. The tryptic or proteolytic digests of proteins, biological actions of
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compounds like quercetin on the growth of cancer cells was studied to the level of the proteome
within the cell by Davis and Hord (2005). It was also found from the same study that quercetin
altered the expression of 20 proteins at least 2-fold, and the proteins included several heat shock
proteins and annexins. These proteins play significant roles in the physiology of apoptosis,
metabolism, and gene regulation. (Wenzel et al., 2004). Irrespective of the compound studied, a
clear understanding of the mechanism of anti-cancerous or anti-proliferative effects can be
visualized by studying the patterns of protein expression inside the cell that is subjected to study.
That way proteomics proves useful.
As evident from the relatively fewer studies on proteins/peptides studied in relation to
cancer therapeutics, compared to non-protein substances we emphasize the need to conduct more
studies that help validate the bio-functional roles of proteins/peptides in cancer therapeutics.
With advent of new processing strategies in rice to improve protein yields, there is a need to
evaluate these rice bran proteins/peptides for their anticancer roles. The following table (2.3) lists
the proteins/peptides that have been so far implicated in anticancer effects.
Table 2.3. List of proteins/peptides with anticancer activities.
Type of cancer

Anticancer agent

Source

Reference

Prostate

Proteins

Soy

Bylund et al., 2000

Breast

Protein

Soy

Badger et al., 2005

Peptides with RGD

Yang et al., 2007

sequence
Calcaelin protein

Mushroom

Ng et al., 2003

(Calvatia
caelata)
Peptide

Rice bran

Kannan et al., 2010 and
Li et al., 2014

Lung

Alpha-lactalbumin

Milk
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Hakansson et al., 1995

Table 2.3. List of proteins/peptides with anticancer activities (cont.).
Type of cancer

Leukemia

Anticancer agent

Source

Reference

Casein and other proteins

Animal

Mahaffey et al., 1985

Peptide fractions

Rice bran

Kannan et al., 2008

Ribosomal inactivating

Seeds of Abrus

Hideki et al., 2004

proteins

precatorius

Lfcin-B peptide

Lactoferrin-B

Yoo et al., 1997

protein

Purification of peptides and characterization
Proteins and their constituent amino acids are present abundantly in many food sources.
The separation of bioactive peptides from enzymatic hydrolysates provides scope to create
functional foods that can slow disease progressions. Isolation and identification of proteins or
peptides of interest for bioactive functional roles is thus a very important step. Peptides are
known to be important biological modulators and proper analytical separation and purification
techniques can alone identify specific amino acid sequences for reproduction and synthesis.
Isolation and separation of protein/peptide of interest from a pool of proteins becomes a
challenging task, because many proteins/peptides can possess closely related physicochemical
properties (Pouliot et al., 2006). Fractionation and purification techniques are normally
performed based on where and for what purpose the final product/molecule is rendered
applicable. For purification of food components expensive methods such as chromatography are
used to achieve purity for industrial applications.
Various preparative chromatographic methods have been used to purify proteins and
peptides, including, ion-exchange chromatography, hydrophobic interaction chromatography,
affinity chromatography and size exclusion chromatography. Out of several separation
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techniques available High Pressure Liquid Chromatography (HPLC) happens to be the most
widely used method for analytic as well as preparative separations of proteins and peptides.
Reverse phase HPLC is extensively employed with (or without) pairing to ion-exchange
chromatography for efficient purification of single peptides from a pool (Byun et al., 2001,
Stepnowski et al., 2005, Kannan et al., 2008). Conventional UV and fluorescence detectors
enable detection of proteins and peptides of interest but, structural characterization of purified
peptides can be achieved by amino acid analysis, SDS–electrophoresis and mass spectrometry
(MS). Furthermore, MS analysis can include matrix-assisted laser desorption/ionization
(MALDI) to enable precise structural information and characterization.
Ion-exchange chromatography is used to separate molecules based on their charge where
the retention time in the solid matrix (column) also depends on the electrostatic interactions. The
isoelectric point (pI) is the most important property of proteins and their products, which is
utilized in effective purification techniques. Various peptides were subjected to ion exchange
chromatography and other effective purification techniques from their native proteins, for
example, Lactoferricin was isolated from Lactoferrin (Dyonisius et al, 1997, Recio et al., 2000)
and Luffacylin isolated from a vegetable (Luffa acutangula) seed protein (Parkash et al, 2002).
Size exclusion chromatography is another technology that can be used to separate
relatively large peptides (>1kDa). The column gel matrix for this method of separation consists
of a definite pore size for the molecules to pass or retain based on their size. Smaller molecules
diffuse faster than their larger counterparts and the differences in the retention time allows for
their separation. Generally, size exclusion when coupled with ion exchange and HPLC can
produce better separation as the molecules are separated by size as well as the net charge which
determines their distinct retention time (Prakash et al., 2002).
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Nisin, a peptide from bacteria classified as bacteriosin, was identified and purified using
a combination of chromatographic methods. The researchers established a two-step process
where the sample were adsorbed on a hydrophobic resin followed by ion (cation) exchange resin
which enabled a 100% recovery of the compound (Stoffels et al., 1993). Using sepharose cationexchange gel elution with NaCl and by HPLC technique using low pressure were studied by
Uteng et al. (2002) which resulted in 90% recovery of the bacterial peptide. Hence,
characterization of peptides can be accomplished using single or combinations of
chromatographic. However, efficiency of the purification process requires various trials of
optimizing the technique and hence substantiates as a challenging action. Recent automation and
sophistication of instruments has aided in quicker and convenient procedures for protein
separations.
High pressure liquid chromatography or Reverse Phase-HPLC has become extremely
popular for protein separation and purification techniques to obtain purified peptides. In reversed
phase, separation is achieved through partition and adsorption where the stationary phase is nonpolar (or less polar than in the mobile phase). The analytes are retained on the column until a
polar solvent (in the case of a mobile-phase gradient) is used to elute them. Large peptides
(>4,000 Da) are analyzed with columns with greater pore diameter (300A) while the smaller
molecular pore sizes (60-100A) are preferred for separation of smaller peptides. The
physicochemical characteristics of peptides, hydrophobic or hydrophilic, influence the choice of
stationary phase used. Acetonitrile is the most widely used organic solvent for peptides since it
has high transparency during UV detection between 200 and 220 nm. Ion-pairing reagents
including organic acids, have been used to increase efficiency in separation and to yield pure
peptides (Piot et al, 1992, Dionysius and Milne 1997, Hoek et al., 1997, Kannan et al., 2010).
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Initial identification followed by purification using RP-HPLC separation technique with Mass
spectrometry and Matrix Assisted Laser Desorption Ionization-Time of Flight were conducted
for peptides obtained from food products with bioactivities and antimicrobial properties
(Shimazaki et al., 1998, Leonil et al., 2000). The following table (2.4) illustrates the types of
HPLC used for separation of food peptides, their separation mechanism and characteristics of
separation.
Table 2.4. HPLC methods involved with food peptides (Nollet, 2004).
HPLC type Separation mechanism
Characteristics
RP-HPLC

Hydrophobic interaction of the
peptides with the stationary phase

IE-HPLC

Ionic interaction of peptides with
anion exchangers or cation
exchangers as stationary phase

SE-HPLC

Size exclusion of peptides on
hydrophilic polymers as stationary
phase

High resolution
High speed
Standard separation procedures
Prediction of retention times
Good detection and reproducibility
Quantitative recovery using volatile
buffers
Moderate capacity in analytical columns
Moderate resolution
High speed
High capacity
Prefractionation of peptides by charge
Wide range of pH
Moderate or low resolution
High speed
Very high capacity
Desalting
Good prefractionation by size
Molecular weight determination
Presence of nonspecific interactions

Characterization of proteins and peptides using proteomic tools
Characterization protocols have been made simpler, quicker and reliable with the arrival
of modern proteomic techniques that aid in precise and quick identification and detection of
structural components of a peptides within a complex as well as pure mixture. Several proteomic
tools were developed based on several factors that are involved in characterizing a compound’s
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purity and to ascertain its functionality. Coupling of chromatography and spectrometry in tandem
has enhanced separation, improved mass determining capabilities, decreased process time and
increased sensitivities. Mass spectrometer and its accessory coupling instruments are the most
popular tools available for studying proteins.
Mass spectrometry (MS)
It is an analytical technique for determination of the elemental composition and chemical
structure of molecules such as peptides. The principle is to ionize chemical compounds to
generate charged molecules or their fragments and measure their mass-to-charge ratios (Horn et
al., 2000). In an MS protocol the sample is impacted with electron beam to ionize the
compounds. The resultant charged particles are subjected to an electric field where the separation
of molecules occurs based on mass-to-charge ratio which are measured to identify the individual
compounds. There are two methods for ionization during MS, electrospray ionization (ESI) and
matrix-assisted laser desorption/ionization (MALDI). The latter is used for thermolabile and nonvolatile compounds with high molecular mass. MALDI is used successfully in biochemical
studies for the analysis of proteins, peptides, glycoproteins, oligosaccharides, and
oligonucleotides (Hillenkamp, 1991). The accuracy of the compounds mass is based on analyzer
type and performance. However, most advanced instruments will be capable of measuring
masses to within 0.01% of the molecular mass of the sample, up to 40,000 Da.
The MALDI technique based ionizing the samples by bombarding with a laser light is the
standard procedure before a low concentration of the sample is pre-mixed with a highly
absorbing matrix compound for the most consistent outcomes. Sputtering of analyte and matrix
ions from the surface of the mixture occurs when the laser energy is transformed into excitation
energy. Since this energy transfer is efficient the analyte molecules are spared from
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decomposition by avoiding excessive direct energy. The time-of-flight (TOF) analyzer attached
to the MALDI uses an electric field to accelerate the ions through the same electric potential, and
measures the time they take to reach the detector. The compounds are identified based on their
velocity to reach the detector which depends exclusively on their mass.
Tandem mass spectrometry (MS-MS) is the most advanced screening method for
structural information about a compound. It uses fragmentation of specific sample ions inside the
mass spectrometer to identify them and the information is pieced together to generate structural
evidence of the intact molecule. A tandem mass spectrometer is a specialized instrument that
displays results in the form of a mass spectrum, which is a graph that shows each specific
molecule by weight (mass) and how much of each molecule is present. It can sort biochemically
important molecules of similar weight in a sample and can detect specific compounds in complex
mixtures based on their characteristic fragmentation patterns. Peptides fragment in a reasonably
well-documented manner where the protonated molecules fragment along the peptide backbone
and also show some side-chain fragmentation with certain instruments. The three different bonds
that can fragment along the amino acid backbone are the NH-CH, CH-CO, and CO-NH (most
common), which give rise to the “b” and/or the “y" ions. Each amino acid residue is indicated by
the mass difference between two adjacent “b” ions, or “y" ions.
Amino acid sequences of peptides
The exact sequence and the number of amino acids that constitute proteins/peptides is
determined by the n-terminal amino acid sequence. Proteins are probed for the occurrences of
functional di- or tri-peptides within their structures. This is to identify critical areas that impart
significant functional characteristics to the protein. Further, these findings provide exact amino
acid composition of functional peptides for in vitro synthesis. Di-deoxy method is the standard
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for N-terminal amino acid sequencing and these studies have been done several times when
peptides are involved. Alcalase treatment of soybean proteins formed low molecular weight
peptides which are isolated and identified to be effective against hypertension. A sequence of 9
amino acids obtained from hydrolysis of rice albumin protein was found to promote immunostimulation. Several peptides ranging in amino acids of about 5-10 have been successfully
isolated and proven beneficial against disease characteristics. Determination of the correct
sequence and number of amino acids that constitute proteins/peptides is by the N-terminal amino
acid sequence of proteins and peptides.
The activity of biologically functional peptides is due to their amino acid composition
and sequence. For example, two peptides purified from canola protein hydrolysate were shown
to inhibit ACE-I activity after purification. The amino acid analysis of the peptides showed 45%
content of aromatic amino acids in comparison to 8.5% of the hydrolysate (Wu et al, 2008).
Many peptides are known to have multifunctional properties as the size of their active sequences
may vary from two to twenty amino acid residues (Meisel and FitzGerald, 2003). For example,
in ß-casein amino acid sequence the peptides 60-70 show immune-stimulatory, opioid and ACEI inhibitory activities. Hence, these sequences are classified as strategic zones and are protected
from proteolysis due to proline residues and high hydrophobicity (Migliore-Samour and Jolles,
1988; Meisel, 1998). There are several examples of multi-functional peptides from various
sources including milk and rice (Vogel, 2012, Kannan et al., 2012). The αs1-casein fraction
194-199 showing immune-modulatory and ACE-I inhibitory activity (Korhonen and Pihlanto,
2003). The C-terminal moiety of κ-casein, residues 106–169, cleaved by chymosin from
Caseinomacropeptide (CMP) during cheese making was reported to have diverse nutritional and
biological significances due to unique amino acid composition. Researchers have suggested
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CMP as a protein source for the treatment of Phenylketonuria, a hereditary disorder in which
aromatic amino acids cannot be metabolized, since CMP does not contain the aromatic amino
acid residues (Leonil et al, 2000).
Proteins can thus be probed for the occurrences of functional di- or tri-peptides within
their structures to identify critical areas that impart significant functional characteristics to the
protein. The findings can also provide amino acid composition of functional peptides and the
precise sequence information can help peptides to be synthesized in large scale for ingredient
formulation as a nutraceutical agent.
Biological activities of soybean peptides
Soy peptides have been studied for disease resistance and also for biological activity
against spread of certain non-pathological diseases. Research has found out that hydrophobic soy
peptides with anticancer activity have arrested cancer cell cycle progression in the in vivo
studies. The mouse monocyte macrophage cell line P388D1 was incubated with the soy peptides.
The peptides arrested the cell growth at the G2/M phase of the cell cycle. The cells were stained
with propidium iodide, and DNA analysis of each phase was done using the Fluorescent
Activated Cell Sorter (FACS) equipment (Kim et al., 2006). Numerous peptides with various
bioactive functions have been identified in soy. Lunasin is one such peptide from soy which is 43
amino acid residues long and has been shown to be chemo-preventive in mammalian cells and in
a skin cancer mouse model against oncogenes and chemical carcinogens. (Jeong H. J. et al.,
2003). In the Bio-pep database (Dziuba J. et al., 2003) more than 1500 different bioactive
peptides like angiotensin converting enzyme (ACE-I) inhibitors and dipeptidyl peptidase IV
inhibitors have been listed. Some peptides are with opioid agonistic and antagonistic,
antioxidative, anticancer, anti-hypertensive, and immuno-modulatory actions. The present
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research is to develop peptides from soy with biological activity against hypertension and cancer
cells.
Emphasizing the amino acid roles in cancer progression, and the lack of studies on
involvement of protein hydrolysates and peptides in ACE-I (potential biochemical agent for
inducing hypertension) and multiple-site cancer (colon, lung, liver, breast, prostate and blood
cancer cell lines) proliferation inhibition, we propose to investigate roles of peptides extracted
from soybeans (an established source of flavonoids and other compounds responsible for antiproliferative effects). Literature information on soybean proteins/peptides on control of cancer
proliferation has been mostly involving soy isoflavones and naturally occurring peptides that
have anti breast-cancerous effects, or other bioactive functions. However, nothing has been done
using high oleic acid soybeans with comparatively higher amounts of protein as well as
methionine and cystine to prepare medium sized synthesizable bioactive peptides. Research in
genetically engineered high oleic acid soybean has a great future, since there is production of
higher quality vegetable oil and utilization of the byproduct from the oil industry in developing
certain nutraceuticals that can be the future of disease prevention and control. Knowing the
amino acid sequences of these peptides would enable the industry to produce synthetic peptides
with equivalent bioactivity.
Studies with soybean components will emphasize that the incidence of cancers are much
lower in Asian countries where soy is used as chief ingredient in the population’s staple diet.
Several technological options available in the literature are on the production, preparation,
gastrointestinal resistance evaluation, identification of specific bioactivities, and separation and
purification strategies for food derived peptides. Depending upon the nature of the bioactivity
and the target site it is critical to consider all the options available before conditions can be
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established for the production of bioactive peptides. With such an understanding peptides
derived from soybean meals have been prepared and evaluated for anti-ACE-I and anticancer
activities. In the following chapters the ways adopted for preparation and characterization
biologically active soybean peptides have been documented.
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CHAPTER 3
Protein content and amino acid profiling of 44 soybean lines developed in Arkansas
(Part of the chapter published in the Journal of American Oil Chemists’ Society, May 2015,
92(7): 1023-1033.)
Abstract
Soybeans are cultivated in the United States chiefly for cooking oil, while the residue
after oil extraction (soybean meal) is mostly used in animal feed formulations. High protein
content in the defatted soybean meals led to its extraction and application in food products due to
its good quality. However, soy protein is naturally deficient in sulfur-containing amino acids,
methionine and cysteine. But, in recent years, plant breeding techniques have been used to
enhance the protein and fatty acid quality in soybeans. In this study, forty four selected soybean
lines were evaluated for their moisture and protein contents and amino acid composition. The
moisture was determined by AACC air oven method, protein content by an automated Kjeldahl
method and the amino acid profiling was conducted based on AOAC official method. The
moisture percentage ranged between 5.2 and 12.9 % among the lines while the protein content on
dry basis ranged between 40 and 53 %. The amino acid analysis showed high methionine content
in the R05-4494 and R05-5491 with ‘high protein and fatty acid’ as yield attributes. High
cysteine content was found in one of the high oleic acid soybean line, CRR05-188, which is
comparable to that in the check lines, UA-4805 and 5601-T. The results indicated that fatty acid
associated attributes in the soybean lines did not influence the protein content. This study will
promote newly developed specialty soybean lines with high oleic acid and high protein content
that can add value to the crop and provide nutritious ingredients for food product manufacturers.
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Introduction
Soybean is an excellent source of protein and oil and is the second major crop grown in
the United States. The USA is the largest producer and exporter of soy in the world and the
forecast for 2014 production is approximately 3.3 billion bushels (~27 kg/bushel) according to
the Crop Production Report by the United States Department of Agriculture (2012). The
American Soybean Association and the regional soybean boards have a major role in producing
better quality soybeans using genetic engineering and plant breeding techniques by improving
various attributes including enhanced yields, pest and disease resistance, lipid quality and
quantity, and protein content and quality (Cober and Voldenga, 2000, Cahoon, 2003). Soybeans
are primarily grown for the edible oil which is separated by various extraction methods, resulting
in a leftover residue called soybean meal. Soybean meal is a major ingredient in animal feed
formulations as a source of complete protein. It is also a chief source of high-quality plant-based
protein in human diet. Hydrolysates prepared from the soybean proteins are in great demand as
ingredients for food applications as well as in protein supplements that provide nutritional and
health benefits (Reynolds et al., 2006, Genovese et al., 2007, de Moura et al., 2008).
Improvements in soybean processing and functional characteristics have diversified the everincreasing demand for soy protein ingredients (Uzzan and Labuza, 2004).
New soybean lines are produced with higher yields, higher protein content, and recently
with higher amounts (up to 80 %) of oleic acid in their lipid composition (Clemente and Cahoon,
2009). A higher percentage of monounsaturated fatty acids such as oleic acid is preferred over
polyunsaturated fatty acids which have lower oxidative stability (O’Keefe et al., 1993, Warner
and Knowlton, 1997). Variations in the plant genes are the cause for differences, not only in the
oil content but also in the concentration of crude protein, possibly even in the amino acid
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composition (Takagi and Rehman, 1996, Mazur et al., 1999, Monteros et al., 2008). Researchers
have found an increase in lysine in the hybridized high oleic acid soybean seeds compared to the
parent lines (Dixon, 1996, Health Canada, 2000). The amino acid composition of the seed
protein depends on the storage protein content, nitrogen supply during the growth phase, and
asparagine levels in the embryonic stage of the plant (Sebastia et al., 2005). There has not been
much research in evaluating the essential amino acid content, specifically sulfur-containing
amino acids in the soy protein from high oleic acid soybean seeds. Oil-extracted soybean meals
contain approximately 1 % residual oil and have 48 % crude protein with all the essential amino
acids required for human health except for the sulfur amino acid methionine (Krishnan, 2005).
This is the first time that amino acid analysis of soybean lines with varying oleic acid
composition has been studied. The 44 soybean lines used in this study were bred for attributes
including yield, protein content, low linoleic acid, high oleic acid content, high yield and high
protein. The major objectives of this study were to analyze the protein and its amino acid
composition among 44 soybean lines.
Materials and Methods
The seeds of 44 soybean lines (R05-4509, R95-1705 (non-GMO), R05-4476, R05-4487,
R05-4473, R05-4507, R05-4492, Satellite, R05-4494, S03-543CR, N98-4445, R05-5491, R055340, R05-4457, R05-4478, R05-4505, R05-5362, Osage, S01-9265, UA-4805, 5601-T, R055351, S04-4729RR, TN01-235, S04-3835 RR, R05-5510, Satellite, N98-4445, Kristine, 5002-T,
IA-3017, TN-5123, R05-4481, R05-5342, R05-5494, CRR05-188, V01-1693, V01-6338, V011702, S01-9364, Ozark, IA-2064, R05-5358, KS-5007) from two Arkansas Agricultural
Research Stations (ARS) based in Fayetteville (FAY) and Stuttgart (STU) were provided by Dr.
Pengyin Chen, Plant breeder and Professor, Department of Crop Soil and Environmental
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Sciences, University of Arkansas. Kjeltec 2200 auto-distillation unit (Foss, Eden Prairie, MN)
was used to determine the protein content in the flour. Rotovapor (Buchi, Flawil, Switzerland)
was used for vacuum distillation and Beckman HPLC system (Fullerton, CA) was used for
quantitative amino acid analysis. An Ika mill (Ika-Werke, Staufen, Germany) was used for
grinding the samples. All chemicals, solvents, and reagents with highest purity were purchased
from Sigma (St. Louis, MO, USA).
Moisture and Protein Content Determination.
The seeds were ground, passed through a 60-mesh sieve, and the flour was collected,
bagged and stored at 5 °C. The moisture percentage of the flour was calculated based on the
AACC official method (2000). The soybean flour samples were weighed in aluminum pans and
dried at 135 °C for 3 h. The moisture percentage was calculated as the ratio between the moisture
lost from the sample and the actual weight of the sample before drying. This was done in
triplicate for all the 44 seed samples. Protein content of the soybeans was performed using the
Kjeldahl method (AOAC, 1997). The soybean flour samples were weighed in digestion tubes
and digested for 1 h at 420 °C after adding the Kjeldahl tablets and 10 mL sulfuric acid. The
samples were distilled and titrated against 0.1 N HCl in the automated Kjeldahl distillation unit.
The protein percentage was calculated with a conversion factor of 6.25 for nitrogen. The
moisture percentage was used to calculate the protein content by dry weight for all the samples.
All analyses were conducted in triplicate.
Determination of Amino acid Composition.
The amino acid analysis of the flour from the 44 lines was conducted using the AOAC
method (1997). The approximate weight of each soybean meal test sample for amino acid
analysis was calculated by the formula: Ws = 1000/Ns; where Ws is the weight of the sample in
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milligrams, and Ns is the nitrogen content (%) in each sample. Performic acid solution was
prepared and kept at room temperature for 30 min and cooled in an ice bath for 15 min before
adding to the samples. All flour samples were weighed into 250-mL Erlenmeyer flasks and
cooled in an ice bath. Five milliliters of performic acid was added to each flask with the sample,
stirred for 15 min, and all flasks were kept in an ice bath for 16 h for oxidation. After oxidation,
the performic acid was decomposed by adding 0.84 g of sodium metabisulfite to each sample
flask under a fume hood and stirring for 10 min. The oxidized products were hydrolyzed in 6 M
HCl-phenol solution for 24 h at temperatures between 110 and 120 °C. The hydrolyzed sample
solution was cooled to room temperature, and 20 mL norleucine solution was added as HPLC
elution standard. The solutions were evaporated using a rotary evaporator under vacuum (until
5–10 mL remained), diluted with sodium citrate buffer and the pH adjusted to 2.2. The volume
of the hydrolyzed sample solution was made up to 50 mL with the buffer solution and stored at 5
°C in polyethylene bottles. The solutions were injected into a C18 ion exchange column (heated
to 70 °C) using an auto-sampler attached to the HPLC system, and the amino acids were detected
based on the absorbance measured at 254 nm. Eluent buffer solutions, procured from Pickering
Laboratories (Mountain View, CA, USA), containing sodium citrate and hydrochloric acid at
varying pH (3.2, 4.2 and 6.4) were used. The elution times of each amino acid on the column
were compared to an amino acid standard and the amount of each amino acid was calculated in
mg/g based on the peak area.
Statistical analysis:
The JMP software from SAS institute (Cary, NC) was used for the statistical analyses –
Student’s t test, analysis of variance, means and standard deviations (P value <0.05). The data
were collected in triplicate for all the experiments.
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Results and Discussion
Moisture and Protein Content.
The moisture percentage in the flour among the 44 soybean lines ranged between 5.2 ±
0.0 and 12.9 ± 0.1 % (Table 3.1). The moisture values varied due to the difference in the
agronomic growing conditions of the lines, moisture content at harvest and the processing
conditions of the 44 lines. Nevertheless, the moisture content did not have a significant impact
on the protein content in the seeds.
The protein percentage among all 44 lines ranged between 40.8 ± 0.2 and 53.5 ± 0.1 %
approximately by dry weight. The differences in the protein content among the soybean lines
could be due to the genetic variation among the soybean lines. There was a statistically
significant difference in the protein content of the soybean lines as shown in Table 3.1. Both
Fayetteville and Stuttgart Agricultural research stations produced high protein lines. The
variation in the protein content among the lines could be attributed to the dissimilarities in the
soils of the two regions. R05-4509 (STU), R05-4476 (STU), R05-4487 (STU), R05-4473 (STU),
and R95- 1705 had the highest protein yields which were not significantly different from each
other according to the Student’s t test (P > 0.05) while R05-4509 (STU) showed the highest
protein content of 53.5 ± 0.1 % among all the lines.
The highest protein content on dry basis (d. b.), 53.5 ± 0.1 % was from high protein line
and fatty acid line, R05-4509, which was not significantly different (statistically) from that of the
high yielding line, R95-1705 with 52.7 ± 0.4 % protein. The protein content of R05-4509 (STU),
R95-1705 R05-4476 (STU), R05-4487 (STU), and R05-4473 (STU) was much higher than
normal and those with high oleic acid, S03- 543CR and N98- 4445A (Fay), are also found to
have significantly high protein content. Lines grown for the high yield and high protein attributes
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had higher protein content than the high oleic acid lines which is consistent with previous studies
(Cober and Voldenga, 2000). Two other high oleic acid lines, CRR05-188 and TN-5123 from the
Fayetteville ARS stations, had 45.2 and 44.5 % protein which are not statistically different from
each other and similar to the ‘check’ lines—N98-4445A foundation and 5002-T. The ‘check’
soybean lines are used as positive control for comparison of an attribute (high yield, high protein
or high oleic acid, etc.) among the new breeds of soybean seeds developed. ‘Foundation’ lines
are those developed by the breeder (copyrighted) for distribution among the growers. The lowest
amount of protein on dry basis was found in the KS-5007 low linolenic acid soybean which is
40.8%.
Amino Acid Content.
The amino acid analysis of the 44 soybean lines showed variability in protein
composition, while the presence of high oleic acid content did not provide a wide variation.
Hence, other components, including isoflavones and oligosaccharides in the seed, could utilize
the available carbon skeletons during development. A positive correlation between protein, lipid,
sugars and isoflavones during the soy seed growth and maturity have been observed in previous
studies (Kim et al., 2006). The essential amino acid composition of the seed protein in 44 lines is
given in Table 3.2. The amino acid composition among the high oleic acid soybeans lines did not
differ significantly (P value <0.05, data not included). High methionine and cysteine content
were observed in lines: R05-4494, R05-5491, 5002 T, Kristine, R05-5362 and R05-5352, which
were 53.7 ± 1.4, 43.5 ± 0.1, 41.8 ± 4.8, 41.0 ± 0.8, 35.2 ± 3.6 and 39.9 ± 0.4 mg/g, respectively.
Table 3.3 shows the list of soybean lines which had the highest amounts of methionine content
which can be sources of complete protein. This could be due to the nitrogen assimilation during
the seed development which determines the amino acid composition of the seeds (Sebastia et al.,
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2005). The methionine content in the six soybean lines (addressed above) are significantly higher
in comparison to egg (34 mg/g) and milk (20 mg/g) proteins (Table 3.4). Cysteine is the other
sulfur containing amino acid which is non-essential to humans but is required for the
maintenance of protein structure and function. Table 3.3 shows the soybean lines which had the
highest cysteine content: R05-4505—35.5 ± 0.3 mg/g, S01- 9265 —30.8 ± 4.8 mg/g, Satellite
STU 23.7 ± 1.5 mg/g and CRR05-188—25.5 ± 3.3 mg/g which is a high oleic acid line. These
values are higher than those found in milk protein (8 mg/g) and are equal or higher in
comparison to egg protein (24 mg/g).
The CRR05-188 is the only high oleic soybean line that showed higher cysteine content,
although its seed protein content is lower in comparison to S03-543CR and N98- 4445A (high
oleic acid lines). This indicates that sulfur amino acid content in soybeans is not related to the
amount of total seed protein. The soybean line S03-543CR showed the highest amounts of
essential amino acids—threonine, valine, isoleucine and leucine among all the lines tested
irrespective of their traits. It also showed significantly high amounts of lysine amino acid when
compared with the 44 soybean lines. This shows that soybean lines bred for high oleic acid can
also provide substantial essential amino acid content along with high protein. The protein content
in the TN-5123 high oleic acid soybean line was not significantly different in comparison to
CRR05-188, but the essential amino acid content was lower in comparison to other high oleic
acid lines. Hence, other factors, including soil environment and growth conditions, affect the
protein formation during seed development.
Among all the soybean lines, the compositions of glutamine, asparagine and lysine amino
acids are highest in that order, respectively (Fig. 1). Glutamine is essential for gut health while
asparagine maintains the integrity of the nervous system (Newburg and Fillios, 1982, Tuohy et
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al., 2003). Lysine is known to be an essential amino acid which helps in serotonin regulation and
has a moderating effect on blood pressure and the incidence of stroke (Tuohy et al., 2003,
Smriga et al., 2002). The amino acid analysis procedure from AOAC official methods (994.12)
was selected to quantify the sulfur-containing amino acids methionine and cysteine. However,
quantification of aromatic amino acids, tryptophan and tyrosine, was affected during hydrolysis
and oxidation and these were not detected during the ion-exchange liquid chromatography.
All 44 soybean lines showed high amounts of lysine which agrees with the accepted
notion that legume seeds are rich in this amino acid (Iqbal et al., 2006). While glutamine and
asparagine were non-essential amino acids, supplementation of lysine is essential to humans
since it is not synthesized in the body. Lysine plays an important role in transamination reactions
and is utilized to produce vital proteins, including elastin and collagen (Eyre et al., 1984, Reiser
et al., 1992, Akagawa and Suyama, 2001). The comparison of essential amino acids (range)
among the tested 44 soybeans and other protein sources including eggs and milk are given in
Table 3.4.
Researchers have engineered quality traits through plant breeding to enhance the sulfur
amino acid content, even though natural mutations in soybeans have also expressed these
beneficial effects. The genetic alterations have been tested specific to the trait loci that trigger the
formation of methionine and cysteine during the seed growth (Fujiwara et al., 1992, Krishnan,
2005). Soil sulfur and nitrogen content during the growth of the soybeans also affects the
methionine and cysteine content in the soybean protein (Krishnan et al., 2005). Other genetic
attributes like high protein, high monounsaturated fatty acid content, and higher yields or disease
resistance may contribute to enhanced sulfur amino acids, but this is inconclusive.
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Conclusion
The protein contents of soybean lines R05-4509, R95-1705, R05-4476 and R05-4487
were higher among all the lines tested. Soybean lines with ‘high oleic acid’ (S03- 543CR and
N98-4445A) were also found to have substantially enhanced protein content (approximately 48
% d. b.). Lines grown for the ‘high protein and fatty acid’ attribute had 47–52 % (d. b.) protein
content which was comparable to that in the ‘high oleic acid’ lines. Amino acid analysis showed
a significantly higher methionine levels (P value <0.05) in soybean lines recognized for protein
and fatty acid content (R05-4494 and R05-4478). Both methionine and cysteine contents were
elevated in the soybean lines attributed for protein and fatty acid.
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Table 3.1. Seed moisture and protein content of selected 44 Aransas-grown soybean lines.
Cultivar1
Moisture %
Protein % (dry basis) Yield Attributes2
R05-4509 (STU) 11.9 + 0.0def 53.5 + 0.1a
High protein and fatty acid
R05-4473 (STU) 13.1 + 0.1def 52.1 + 0.2b
High protein and fatty acid
R05-4507 (STU) 12.0 + 0.0kl
50.1 + 0.1c
High protein and fatty acid
R05-4492 (STU) 11.5 + 0.0efg 49.6 + 0.6cd
High protein and fatty acid
R05-4494 (STU) 11.8 + 0.3efg 48.6 + 0.0def
High protein and fatty acid
R05-4457 (STU) 5.3 + 0.1rs
47.4 + 0.2fghij
High protein and fatty acid
R05-4478 (STU) 6.1 + 0.1pqrs 47.4 + 0.1fghij
High protein and fatty acid
R05-4505 (STU) 11.4 + 0.1a
47.3 + 0.1ghijk
High protein and fatty acid
R05-4481 (STU) 12.6 + 0.1efg 45.2 + 0.3nop
High protein and fatty acid
R95-1705 (FAY) 6.4 + 0.0qrs 52.7 + 0.4ab
High yield
Osage (FAY)
6.1 + 0.1pq 46.7 + 0.3ijkl
High yield
S01-9265 (FAY) 9.4 + 0.2kl
46.5 + 0.2ijklm
Low saturated fat
Satellite (FAY)
6.7 + 0.2opq 45.7 + 0.3lmnop
Low saturated fat
V01-6338 (FAY) 5.7 + 0.1qrs 43.7 + 0.2qr
Low saturated fat
UA-4805 (STU)
11.6 + 0.0bcde 46.4 + 0.6ijklmn
Check
5601-T (STU)
11.2 + 0.0bcde 46.4 + 0.2jklmn
Check
5002-T (STU)
11.7 + 0.0efghi 45.2 + 0.3nop
Check
S03-543CR (FAY) 6.2 + 0.2pqr 48.4 + 0.5defg
High oleic acid
N98-4445A (FAY) 8.4 + 0.1m
48.1 + 0.4efg
High oleic acid
TN-5123 (FAY)
7.6 + 0.2mno 45.2 + 0.3nop
High oleic acid
CRR05-188 (FAY) 6.4 + 0.0pq 44.5 + 0.4pq
High oleic acid
S04-4729RR
7.9 + 0.3bcde 46.1 + 0.1klmno
Low linolenic acid
(FAY)
TN01-235 (FAY) 8.2 + 0.3m
46.0 + 0.6lmno
Low linolenic acid
S04-3835 RR
8.1 + 0.1mn 46.0 + 0.4lmno
Low linolenic acid
(FAY)
Kristine (FAY)
6.2 + 0.0abcd 45.4 + 0.8mnop
Low linolenic acid
IA-3017 (FAY)
7.9 + 0.2hijk 45.2 + 0.2nop
Low linolenic acid
V01-1693 (FAY) 9.7 + 0.1mn 43.8 + 1.4qr
Low linolenic acid
V01-1702 (FAY) 10.3 + 0.0mn 43.7 + 0.6qr
Low linolenic acid
S01-9364 (FAY) 7.1 + 0.1nop 43.5 + 0.8qr
Low linolenic acid
IA-2064 (FAY)
5.2 + 0.0s
42.8 + 0.2r
Low linolenic acid
KS-5007 (FAY)
10.5 + 0.2l
40.8 + 0.2s
Low linolenic acid
Ozark (FAY)
8.3 + 0.0m
43.2 + 0.3r
Conventional
R05-4476 (STU) 11.6 + 0.0jkl 52.6 + 0.1ab
Fatty acid
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Table 3.1. Seed moisture and protein content of selected 44 Aransas-grown soybean lines
(cont.).
Cultivar1
Moisture %
Protein % (dry basis) Yield Attributes2
R05-4487 (STU) 11.9 + 0.0def 52.3 + 0.2ab
Fatty acid
Satellite(STU)
12.0 + 0.0defg 48.9 + 0.1de
Fatty acid
R05-5491 (STU) 10.4 + 0.1fghij 47.6 + 0.2efghi
Fatty acid
R05-5340 (STU) 10.7 + 0.4abc 47.4 + 0.5fghij
Fatty acid
R05-5362 (STU) 10.8 + 0.2ab 46.8 + 0.2hijkl
Fatty acid
R05-5351 (STU) 11.5 + 2.1pqr 46.3 + 0.8jklmno
Fatty acid
R05-5510 (STU) 9.9 + 0.1cde 45.7 + 0.4lmnop
Fatty acid
R05-5342 (STU) 12.9 + 0.1ijk 45.1 + 0.4op
Fatty acid
R05-5494 (STU) 11.8 + 0.1ghij 44.6 + 0.3pq
Fatty acid
R05-5358 (STU) 9.7 + 0.1efgh 41.0 + 0.2s
Fatty acid
Values given are averages of three replications ± standard deviation and those not connected by
same letter in each column are significantly different (P<0.05). 1STU is abbreviated for Stuttgart
and FAY is abbreviated for Fayetteville. 2Yield attributes are the traits specific to the breed of
the developed lines. (Rayaprolu et al., 2015).
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Table 3.2 (a-h). Essential amino acid composition (mg/g protein) in 44 soybean lines grown
in the state of Arkansas.
(a)
Amino acid
R05-4509 R95-1705 R05-4476 R05-4487 R05-4473 R05-4507
Cysteine
15.2±0.0ab 14.8±0.4a 15.1±0.5ab 14.5±0.7a 13.4±0.8a
14.6±0.3a
mn
l
m
lm
k
Threonine
44.1±0.7
41.8±0.6
43.7±0.7
42.2±0.5
36.8±0.5
41.6±0.6l
Valine
31.4±0.9h 40.7±0.5l 35.5±0.8ij
29.5±0.6g 23.1±0.6cd 38.2±0.5k
Isoleucine
32.7±0.8jk 40.2±0.3p 37.1±0.8n
32.0±0.5jk 22.3±0.5e
36.2±0.4m
Leucine
67.4±0.7k 68.9±0.5l 67.4±0.6k
64.2±0.6i
55.6±0.5de 64.5±0.3i
q
s
rs
p
Lysine
109.0±1.0 113.5±0.9 112.0±0.9 107.3±1.3 101.6±0.9m 109.5±0.7q
Methionine
22.3±1.2f
24.3±0.9g 23.5±1.0g
20.6±1.1ef 19.1±0.7e
21.4±0.9f
Phenylalanine 40.5±0.9j
46.7±0.6m 45.1±0.8lm 46.0±0.9m 41.4±0.6k
45.4±0.4lm
Histidine
53.8±0.6jk 56.3±0.4l 54.7±0.6k
51.6±0.5i
44.9±0.5g
52.7±0.4j
(b)
Amino acid
Cysteine
Threonine
Valine
Isoleucine
Leucine
Lysine
Methionine
Phenylalanine
Histidine
(c)
Amino acid
Cysteine
Threonine
Valine
Isoleucine
Leucine
Lysine
Methionine
Phenylalanine
Histidine

R05-4492
16.5±0.0b
21.0±0.0ef
29.2±0.1g
24.3±0.1f
66.7±0.4jk
109.7±1.5q
26.4±0.3h
47.1±0.1n
52.5±0.1j

R05-5340
14.6±0.6a
19.4±0.3d
35.0±1.0ij
31.8±0.3j
69.6±0.5l
104.2±0.9o
33.6±1.3j
47.6±1.6n
55.1±0.6l

Sat (STU)
23.7±1.5e
21.8±0.0ef
22.7±0.1c
22.0±0.0e
57.8±0.4ef
60.7±0.3g
17.1±0.1d
35.4±0.1fg
33.6±0.0cd

R05-4457
21.3±2.3cd
21.6±0.0ef
23.8±0.0cd
23.6±0.0ef
58.1±0.2f
60.0±0.1g
14.2±0.0bc
35.0±0.2fg
33.9±0.1cd

R05-4494
15.9±0.1ab
20.0±0.1de
25.6±0.6e
22.5±0.0e
68.3±0.2kl
98.1±6.5k
53.7±1.4p
31.1±2.7d
49.3±0.4h

S03-543CR
14.2±0.5a
45.2±0.7n
42.1±0.5m
39.2±0.6o
69.1±0.5l
123.8±0.8u
24.3±1.2g
48.0±0.4o
56.2±0.5l

R05-4478
15.3±0.1a
19.9±0.2d
26.5±0.4ef
22.9±0.0ef
65.4±0.3ij
107.5±0.9p
33.3±4.3k
44.5±0.3l
52.7±0.3j

R05-4505
35.1±0.3h
21.2±0.0ef
20.2±0.1bc
19.6±0.1d
56.6±0.4e
60.2±1.0g
13.8±0.1b
34.7±0.2f
32.2±0.2c
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N98-4445A
14.9±0.3a
18.5±0.6d
27.9±0.4f
25.9±0.3f
51.3±0.5b
53.4±0.7de
14.2±0.0bc
30.1±0.2c
30.9±0.2b

R05-5362
14.9±0.2a
18.6±0.8d
36.4±0.8j
31.3±0.2j
68.3±0.6kl
103.3±0.1mn
35.2±3.6l
47.4±0.9n
54.9±0.2kl

R05-5491
15.5±0.6ab
21.3±0.4ef
33.8±1.4i
31.6±1.7j
71.2±3.9m
117.2±7.0t
43.5±0.1o
46.1±3.0m
56.6±2.5l

Osage
14.7±0.4a
41.4±0.7l
24.7±0.9d
24.2±0.7f
60.4±0.5fg
104.1±1.1o
19.9±0.5e
44.1±0.8l
51.5±0.6i

Table 3.2 (a-h). Essential amino acid composition (mg/g protein) in 44 soybean lines grown
in the state of Arkansas (cont.).
(d)
Amino acid
S01-9265 UA-4805 5601T
R05-5351 S04-4729RR TN01-235
g
a
a
Cysteine
30.8±4.8
13.1±0.6
14.3±0.6
16.4±0.1b 19.2±1.2c
15.4±0.2ab
Threonine
21.9±0.0ef 16.7±0.6c 14.9±0.3b
20.0±1.6de 27.0±1.7h
13.7±0.1a
Valine
22.7±0.0c 29.6±0.7g 24.9±1.2de 31.6±0.5h 30.0±3.6gh
19.7±0.9b
Isoleucine
22.3±0.1e 27.0±0.1g 17.2±0.1bc 29.7±0.4i
31.4±4.2j
14.6±0.0a
Leucine
57.7±0.3ef 62.3±0.5gh 57.6±0.5ef
53.3±0.8c 65.8±3.6ij
43.5±0.1a
Lysine
61.8±0.0h 96.1±0.2j
102.9±0.3m 50.1±0.0c 56.0±3.0f
48.3±0.1bc
Methionine
16.0±0.8d 34.5±3.8l
33.0±3.2j
13.7±0.2b 28.5±0.7ij
12.4±0.0a
Phenylalanine 34.1±0.1f 41.3±1.3k 44.6±1.4l
32.0±0.6de 33.4±2.9e
26.6±0.0b
Histidine
34.5±0.0d 50.0±0.4hi 45.3±0.7g
32.8±0.2c 38.3±2.3f
27.3±0.0a
(e)
S04Amino acid
3835RR
Cysteine
15.7±0.2ab
Threonine
20.8±1.4de
Valine
36.4±0.4j
Isoleucine
34.6±0.2l
Leucine
56.0±1.5e
Lysine
54.3±0.0c
Methionine
13.7±0.7b
Phenylalanine 36.4±0.1h
Histidine
34.4±0.2d
(f)
Amino acid
Cysteine
Threonine
Valine
Isoleucine
Leucine
Lysine
Methionine
Phenylalanine
Histidine

IA-3017
20.1±0.4c
24.8±0.6g
35.8±0.8ij
35.6±0.1lm
66.1±0.7jk
53.7±2.1de
20.2±1.0ef
37.0±0.4h
38.2±0.5f

R05-5510
16.6±0.0b
19.5±1.3d
32.6±0.0h
30.9±0.0i
71.6±0.2m
111.0±1.4r
32.5±1.9 j
50.2±1.5p
58.7±0.7m

Sat (Fay)
22..0±1.9de
21.1±0.0ef
19.1±0.0b
16.9±0.1b
54.0±0.0d
63.9±0.4i
18.0±0.0d
33.7±0.0e
32.3±0.0c

N98 (Fdn)
14.0±05a
43.5±0.6m
35.4±0.8ij
34.4±0.8l
62.8±0.8h
109.6±1.4q
23.4±0.9g
45.3±1.0lm
52.0±0.6j

Kristine
16.2±0.7b
21.7±0.7ef
30.6±1.6gh
27.6±1.6g
68.6±4.0kl
102.9±0.0m
41.0±0.9n
39.0±0.1i
53.9±1.9jk

TN-5123
15.0±0.1ab
20.0±0.7de
16.8±0.0a
16.7±0.8b
51.9±0.8b
61.0±1.7h
16.7±1.9d
24.9±0.9a
30.0±1.1b

R05-4481
19.7±0.1c
24.0±1.2g
25.9±0.4e
22.7±0.0e
57.9±0.0ef
62.1±0.4h
14.2±1.2bc
34.5±1.0f
33.1±0.2cd

R05-5342
16.7±0.0b
24.2±0.1g
27.0±0.2f
28.0±0.0gh
60.8±0.0fg
50.5±1.7c
20.2±2.5ef
29.3±0.7c
34.2±0.0d

R05-5494
16.6±0.2b
23.5±0.2fg
26.5±2.3ef
27.4±2.5g
57.5±0.9ef
52.8±0.5d
26.4±2.0h
29.1±1.2c
32.7±0.7c
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5002T
14.5±0.2a
16.8±1.3c
22.0±0.4c
19.5±1.2d
67.1±0.1k
103.0±0.7mn
41.8±4.8n
38.6±0.2i
54.5±2.1k

CRR05-188
25.5±3.3f
19.8±0.0d
31.7±0.0h
32.3±0.1jk
66.4±0.2jk
61.8±0.5h
15.8±0.1c
38.7±0.3i
38.5±0.0f

Table 3.2 (a-h). Essential amino acid composition (mg/g protein) in 44 soybean lines grown
in the state of Arkansas (cont.).
(g)
Amino acid
V01-1693 V01-6338 V01-1702 S01-9364 Ozark
IA 2604
c
b
a
b
b
Cysteine
20.3±0.4
16.4±0.1
14.7±0.3
16.7±0.2
16.0±0.5
20.6±0.1c
Threonine
22.0±0.9f 17.5±1.5cd 21.6±0.9ef 19.8±0.0d 44.2±0.7mn
22.9±1.5f
Valine
26.9±0.5ef 23.1±1.4cd 24.2±1.0de 30.6±1.7gh 32.2±0.9h
31.4±0.2h
Isoleucine
25.4±0.1f 17.3±1.1bc 32.3±1.7jk 27.7±1.6g 31.3±0.8j
30.7±0.1i
Leucine
61.1±0.6g 53.1±0.3c 58.9±0.2f 65.6±0.7j
64.5±1.0i
59.5±0.1f
Lysine
60.9±0.8g 49.1±0.4b 46.8±1.3a 111.8±2.7r 100.1±1.3l
54.5±0.1e
Methionine
21.4±0.4f 20.9±2.0ef 27.8±0.3hi 32.6±1.5j
20.3±0.6ef
14.0±0.4bc
Phenylalanine 33.1±1.5e 26.6±0.2b 26.8±0.6 b 41.2±2.9k 48.5±0.9o
33.1±0.8e
Histidine
35.3±0.3d 30.1±0.6b 31.4±1.0 b 55.9±1.1l
54.2±0.7k
36.3±0.1e
(h)
Amino acid
Cysteine
Threonine
Valine
Isoleucine
Leucine
Lysine
Methionine
Phenylalanine
Histidine

R05-5358
16.3±0.2b
19.7±0.6d
21.8±0.9c
19.2±1.0d
73.3±1.1n
137.8±3.0v
39.9±0.4m
36.5±1.2h
50.7±1.5hi

KS-5007
16.4±0.1b
34.2±0.2j
32.1±0.1h
27.2±0.1g
63.8±0.2i
96.9±0.3j
26.1±0.1h
44.2±0.0l
54.2±0.1k

Values are means ± standard deviation of triplicate analysis and those not connected by same
letter in each row are significantly different from each other (P<0.05). Soybean lines: Sat (Fay) =
Satellite (Fayetteville); Sat (STU) = Satellite (Stuttgart); N98 (Fdn) = N98-4445A (Foundation).
(Rayaprolu et al., 2015).
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Table 3.3. Soybean lines with comparatively higher methionine and cysteine content (mg/g
of protein) among the tested soybean lines.
Soybean line
R05-4494
R05-5491
5002-T
Kristine
R05-5362
R05-5358
UA-4805
R05-4478
Soybean line
R05-4505
S01-9265
Satellite STU
CRR05-188

Methionine (mg/g)
53.7 ± 1.4a
43.5 ± 0.1b
41.8 ± 4.8bc
41.0 ± 0.8bc
35.2 ± 3.6d
39.9 ± 0.4bc
34.5 ± 3.8d
33.3 ± 4.3d

Yield Attribute
High protein and fatty acid
Fatty acid
Check
Low linolenic acid
Fatty acid
Fatty acid
Check
High protein and fatty acid

Cysteine (mg/g) Genetic Attribute
35.1 ± 0.3a
30.8 ± 4.8a
23.7 ± 1.5b
25.5 ± 3.3ab

High protein and fatty acid
Low saturated fat
Fatty acid
High oleic acid

Values are means ± standard deviation and those not connected with same letter are significantly
different (P<0.05). STU = Stuttgart. (Rayaprolu et al., 2015).
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Table 3.4. Comparative analysis of essential amino acid composition (mg/g protein) of egg,
milk and soy protein.
Amino acid
Egg protein* Milk protein*
Soy protein#
Cysteine
24
7.9
13.1 - 35.1
Threonine
47.8
47.3
14.9 - 45.2
Valine
48.2
63.8
16.8 - 42.1
Isoleucine
51.4
68.5
14.6 - 40.2
Leucine
82.9
103.5
43.5 - 73.3
Lysine
66.4
68.3
46.8 - 137.8
Methionine
34.9
20.2
12.4 - 53.7
Phenylalanine 59.5
46.7
24.9 - 50.2
Histidine
23.5
21.8
27.3 - 58.7
*
#
Source: FAO. Accessed at: www.fao.org/docrep. Values for soy protein are from the 44
soybean lines that are presented as a range. (Rayaprolu et al., 2015).
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Figure 3.1. One-way analysis of amino acid profile among the 44 soybean lines.
The mean weight (mg/g of protein) from amino acid analysis are shown for each amino acid
detected in the protein. (Rayaprolu et al., 2015).
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CHAPTER 4
Preparation of gastro-intestinal resistant peptide fractions from N98-4445A, R95-1705 and
S03-543CR soybean lines, and their ACE-I inhibitory activities
(Parts of the chapter published in Food Research International Journal, 2013, 50: 282-288 and
in the Journal of American Oil Chemists’ Society, 2015, 92(7): 1023-1033.)

Abstract
Soy is an abundant and relatively inexpensive source of proteins which are known for
their high nutritional values and excellent nutraceutical and functional properties. Enzymatic
digestions of soy allergenic proteins are of interest, since, enzymatic digestion is done not only to
get rid of a large portion of allergenic proteins but also obtain peptides. Potentially
hypoallergenic peptides thus obtained may be considered for unexplored bio-functional
attributes. In this study protein isolates were prepared from three selected soybean lines, R951705 (high in protein), N98-4445A (high in oleic acid and protein) and S03-543CR (high in oleic
acid and protein) with highest purity (90%). Conditions were optimized for enzymatic digestion
of the protein isolate with Alcalase (subtilisin) using response surface methodology. The protein
hydrolysates obtained were exposed to simulated gastric and intestinal juices for testing their
resistance to human digestive enzymes (GI). The resistant hydrolysates were then separated
based on molecular cut-off sizes into three different fractions using ultrafiltration membranes.
This resulted in GI resistant protein fractions with distinct molecular cut-offs: <5kDa, 5-10kDa
and 10-50kDa that were freeze dried. Furthermore, the GI resistant fractions were tested for
angiotensin-I-converting enzyme (ACE-I) inhibition activity. The 5-10kDa protein hydrolysate
(500 μg/mL) from R95-1705 showed highest inhibition of the ACE-I by 49 %. The results from
this study will promote the use of high oleic acid soybeans as a source of protein and peptides
with functional activities.
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Introduction
Proteins from plant sources are part of human diet which are incorporated into several
products in the food industry. This is due to their functional properties which are beneficial for
maintaining human health. Soybean is a widely cultivated legume for edible oil and the coproduct or residue after oil extraction is chiefly used as meal in farm animal feed. The soybean
meal or oil extracted residue is mainly known for the protein content which has been
increasingly consumed by humans as a good substitute for animal protein. There are various
methods to separate native proteins from seed flour without denaturing it and retaining its
properties. The seed flour can be treated with enzymes to prepare the protein isolate by digesting
the starch with alpha-amylase (Shih and Daigle, 1997, Tang et al., 2002). However, alkaline
hydrolysis is the simplest method of solubulizing the protein, and separating it from the starch.
Researchers have shown that soy proteins lose their allergenic properties when digested with
proteases. The resulting hydrolysates when tested for their binding abilities to either a
monoclonal antibody or sera obtained a negative result (Obata et al., 1998; Yamanishi et al.,
1996)). Obata et al (1998) reported reduction of allergenicity in tofu (soybean surd) after
enzymatic digestion. Reduction in allergenicity after enzymatic digestion of soybean grains was
demonstrated by Yaminishi et al (1996). This also leads to the generation of pure peptides
(Kannan et al., 2010).
Alcalase and liquipanol are two proteases with broad specificity that can cleave the
proteins either at Arg-Arg residues or at uncharged carboxy terminal end residues. Enzyme
specificities provide the ability to cleave the substrate proteins at specific sites. This information
for various proteases commonly used in food protein hydrolysis are given in Table 4.1. Bioactive
peptides thus released can potentiate biological effects with even a fraction of them being
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absorbed in our body. However, specificity and extent of hydrolysis are important factors that
need to be controlled to improve functional properties of food proteins and peptides. The
solubility of proteins increases with increase in degree of hydrolysis (DH) possibly due to the
reduction in molecular weight and an increase in the number of polar groups (Nielsen, 1997).
Degree of hydrolysis represents the proportion of peptide bonds hydrolyzed and it is calculated
using the equation DH = (hn x 100)/htot where hn is number of peptide bonds hydrolysed and htot
is total number of peptide bonds present in the parent protein. The units of h and htot are both
meq/gm (Adler-Nissen, 1986). The htot of a protein is calculated from the amino acid
composition of the specific protein being hydrolyzed (Adler-Nissen, 1986). During hydrolysis, a
new carboxyl and a new amino group is released for each cleaved amide bond. The number of
hydrolyzed peptide bonds can be calculated by determining the number of newly formed Nterminal or C-terminal groups in hydrolysates. The amount of released a-amino groups can be
measured by using reagents that react specifically with amino groups, yielding compounds that
can be detected spectrophotometrically. Reagents generally used are o-phthaldialdehyde (OPA),
ninhydrin, and trinitrobenzenesulphonic acid (TNBS).
Proteins have proved to be excellent sources for bioactive peptides, especially in reducing
hypertension, which is a precursor for heart disease (Leppälä, 2000, Palatini and Julius, 2009).
Inhibition of angiotensin-1-converting enzyme (ACE-I) activity has a potential link to a
hypertension lowering effect, by preventing the conversion of angiotensin I to Angiotensin II,
where the latter compound is responsible for contracting the epithelial layer of arteries causing
an increase in blood pressure (Boudier et al., 1992). Previous studies have shown that peptides
derived from soybean protein with limited enzymatic hydrolysis possess ACE-I inhibitory
activity (Wu and Ding, 2002, Kuba et al., 2005) and other bio-activities (Rayaprolu et al., 2013).
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There have been no studies determining the presence of higher than normal amounts of
methionine from high oleic acid soybean meals, or the influence of amino acid content and
sequence which can elicit significant biological activities. The objective of this study was to test
for ACE-I inhibitory activity of the peptide fractions obtained from previous research. Foodderived proteins and peptides have already been considered for interesting applications as
medical foods or pharmaceutical preparations. This is the first time that amino acid analysis of
soybean lines with varying oleic acid composition and ACE-I inhibitory activity assessment of
Alcalase enzyme-derived peptides from their protein isolates has been studied.

Materials and Methods
The seeds of 44 soybean lines, N98-4445A, R95-1705 and S03-543CR, were obtained
from Dr. Pengyin Chen, Plant breeder and Professor, Department of Crop Soil and
Environmental Sciences, University of Arkansas. Food grade enzyme Alcalase 2.5L (EC
3.4.21.62) was purchased from Novozyme (Bagsvaerd, Denmark) for preparing the protein
hydrolysates.
Preparation of soy meal and protein extraction
Seeds of all three soybean lines were provided by Dr. Pengyin Chen (Soybean breeder,
University of Arkansas, Fayetteville, AR, USA). The seeds from two high oleic acid soybean
lines (N98-4445A and S03-543CR) and one high protein line (R95-1705) were ground and
sieved (250 microns) to obtain uniform particle size. The lipid was extracted using the solvent Nhexane (1:3 w/v ratio of flour: solvent) and the lipid content of the meal was determined by the
Soxhlet method (AOAC, 1995). The meals were suspended in de-ionized (DI) water (10% w/v)
and protein isolates were prepared by alkali extraction method (pH 9.5 at ambient temperature
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for 3 hr) using 3N NaOH solution. The supernatants were separated by centrifugation at 3000 g
for 15 min and the residue was re-extracted by repeating the process. The collected supernatants
for each soy line were mixed to prepare the isolate using isoelectric precipitation at pH 4.5. The
final pH was adjusted to 7.0 and the three SPIs were freeze dried. The protein percent was
determined by the Kjeldahl method based on a conversion factor of 6.25 for Nitrogen (AOAC,
1995).
Optimization of conditions for enzymatic hydrolysis with Alcalase
The conditions for optimization of enzymatic hydrolysis using Alcalase were determined
based on the Box-Behnken Design of the Response Surface Methodology (RSM) (Ma and
Ooraikul, 1986). The SPI was mixed with DI water (1:10 w/v) and homogenized. Enzymes were
purchased from Novozyme Inc. (Bagsvaerd, Denmark). The suspensions were subjected to
treatments involving four factors at three levels in the design viz., pH (6.5, 7.5 and 8.5), time (30,
60 and 90 min), temperature (55, 62.5 and 70 °C), and enzyme concentration (1, 3.5, and 5
Anson units). The enzyme was inactivated at 85 °C for 3 min; the hydrolysates were cooled to
ambient temperature and centrifuged at 3,000 g for 10 min. The degree of hydrolysis (DH) was
determined using the OPA method in the supernatants that were collected. DH is defined as the
percentage of peptide bonds cleaved from the total number of peptide bonds in the protein
(Mahmoud et al., 2006). Ten micro liters of the samples were added to 3 mL of OPA reagent and
the solutions were left to stand for 2 min before taking the spectrophotometer reading at 340 nm
(Adler-Nissen, 1978). Blank was prepared using 400 µL of DI water in 3 mL of OPA reagent.
400 µL of 0.01% serine solution in 3 mL of the reagent was used as a standard. The optical
density (OD) values of all the samples were recorded and the following formulae were used to
calculate the degree of hydrolysis (Neilsen et al., 2001):
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Serine-NH2 = (SampleOD-BlankOD)/(StandardOD-BlankOD)*0.9516*V*100/X*P
Where, V = sample volume; X = amount of protein in the sample; and P = protein % in sample.
Hydrolyzed peptide bonds H = (Serine-NH2-β)/α, where α and β value for soy are 0.248, and
0.97 respectively. Degree of hydrolysis DH = H/Htot * 100, where Htot is the total number of
peptide bonds in soy, which is 7.8 (Neilsen et al., 2001).
Preparation of gastro-intestinal environment resistant peptide hydrolysates with molecular
sizes, <5 kDa, 5-10 kDa, and 10-50 kDa
The simulated gastro-intestinal (GI) juice was prepared mimicking the human GI tract
secretions for treating the protein hydrolysates after Alcalase treatment (Kannan et al., 2008).
Resistance to gastric juice was determined by treating the protein hydrolysates with Pepsin (0.32
g/100 mL) after adjusting the pH to 2.0 using 3N hydrochloric acid solution and stirring for 1hr
at 37 °C. The enzyme was inactivated by adjusting the pH to 7.2 and the contents were
centrifuged at 3000g for 10min to separate the supernatant. The pH of supernatant was adjusted
to 8.0 using 3N sodium hydroxide solution and enzyme Pancreatin (0.1 g/100 mL) was added to
test for resistance against the intestinal juice. The protein hydrolysates were stirred for 1hr at 37
°

C before inactivating the enzyme in water bath at 85 °C for 3min. The GI treated peptide

hydrolysates were centrifuged at 3000 g for 10 min and the supernatants were passed through the
membrane filters of Romicon ultrafiltration system (Koch membrane systems, Wilmington, MA,
USA) with molecular cut-off sizes of 5, 10 and 50kDa. The hydrolysates were passed through
each column starting with 5 kDa as the permeates were collected and retentates were passed
through 10 kDa and then through a 50-kDa column following the similar process. The specific
peptide fractions, <5, 5–10 and 10–50 kDa, were obtained as a results of ultrafiltration process.
All the fractions were freeze dried and stored at 5 °C. Further study included testing the peptide
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fractions for ACE-I inhibitory activity which was compared with that of non-GI resistant
fractions.
ACE-I Inhibitory Activity Assay
A modified method of Cushman and Cheung (1971) was used to conduct the ACE-I
inhibition activity assay. Protein hydrolysates at 500 µg/mL (30 μL), N-hippuryl-L-histidyl-Lleucine (HHL: 150 μL, 6.5mM), and ACE-I (25 μL, 2.5 mU) were incubated at 37 °C for 1 h.
Hydrochloric acid (250 μL, 1N) and ethyl Acetate (1.5 mL) were added to stop the reaction, and
the contents were mixed by vortexing before centrifugation at 2000 g for 5 min. One milliliter of
the top layer (containing hippuric acid extracted with ethyl Acetate) was collected, and ethyl
Acetate was removed using a roto vapor. The residual hippuric acid is dissolved with deionized
water (1 mL) and absorbance was measured at 228 nm. Captopril (10mM) was used as positive
control while a solution containing ACE-I and HHL was used as blank solution. Inhibition of
ACE-I was calculated using the formula:
% inhibition = 1- [(Abstest – Absblank) / Absblank] x 100.
The % ACE-I inhibition was defined as the percentage of ACE-I activity inhibited by a specific
amount of peptides. A dose response study was conducted for the fraction with highest ACE-I
inhibition using fraction concentrations between 200 and 1200 μg/ mL with increments 200 μg/
mL using the above method. The date from the dose response was used to determine the IC50
value for the peptide with highest activity.
Purification of the fractions with highest ACE-I activity
A reverse phase HPLC analysis of the peptide fractions with highest ACE-I activity was
conducted with a two solvent system. Solvent A was prepared with 0.1% Trifluoro Acetic acid in
Millipore water and solvent B was 50% Acetonitrile in water with 0.1% Trifluoro Acetic acid. A
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linear solvent gradient was sued for a 75 minute run with a 1 mL/min flow rate. Solvent A had a
gradual decrease in gradient from 100% to 0% while solvent B had 0 to 100% gradient over the
75 min run. A C18 protein separation column (Sigma Aldrich, MO, USA) was used in isolating
the single peptides.
Statistical analysis:
The JMP software from SAS institute (Cary, NC) was used for the experimental design
and all the statistical analyses. Statistical analysis of the effect of four factors viz., pH, enzyme
concentration, time and temperature on the degree of hydrolysis was conducted using the BoxBehnken design of the response surface method. The optimized conditions for the degree of
hydrolysis were determined based on the 3 point prediction profiler and a P value <0.05 was
used for all the analyses.

Results and Discussion
Purity of protein isolates
Previous literature has shown that alkali extraction is an optimized method to isolate
proteins for studying their functional properties (Okezie and Bello, 1988). Hence, protein from
the three soy meals was extracted at a lower pH of 9.5 at ambient temperature and the process
was repeated to maximize the yield without affecting the protein quality. Protein contents of the
soybean lines were ~91 % for S03-543CR and N98-4445A, and ~93 % for R95-1705 (Table 4.2)
signifying high protein purity.
Optimization of conditions for enzymatic hydrolysis
The objective was to hydrolyze the proteins present in the prepared high-purity soy meal
protein isolates to liberate peptides that may be of bioactive value. In order to accomplish
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hydrolysis of the proteins, a Box-Behnken RSM statistical design was chosen to evaluate
combinations of variables such as pH, temperature, enzyme concentration and time of hydrolysis
at three levels for optimal hydrolysis (Table 4.3). Degree of hydrolysis (DH) was determined for
each combination and an optimum value was selected to achieve optimal hydrolysis of the
proteins that resulted in both high and low molecular weight fractions. The amount of enzyme
added and the pH of the suspension had shown significant effect on the DH which ranged
between 18.8 % and 57.4 %. A DH of 30 % was selected as the optimum condition at pH 7,
enzyme concentration of 1.675 AU, temperature of 55 0C for 45 min (Figure 4.1). The optimized
conditions were selected to allow formation of considerable size peptides and to prevent total
digestion of the protein when exposed to the gastro-intestinal juices.
GI resistance and preparation of peptide fractions
While larger size peptide fractions are known for their functionality in food products (Wu
et al., 1998), smaller size peptide fractions were also considered as they have been shown to
have higher potency (Wu and Ding, 2002) for wider applications. Simulated GI resistance
demonstrated the resistant of peptides to digestion in the GI tract and could be available for
absorption through the intestine. Three molecular cut off membrane columns of 5, 10 and 50kDa
were used to fractionate the peptide hydrolysates and permeates and retentates were collected
from each column. The nine specific fractions of <5kDa, 5-10kDa and 10-50kDa for each soy
line were collected to test the cancer cell inhibitory property.
Activity of Protein Hydrolysates.
Three soybean lines, S03-543CR and N98-4445A (with high oleic acid) and R95-1705
(high yield and non-GMO), were selected based on their high protein content. The alkali
extraction method provided >90 % protein yield in the isolates (yield: >83 % d. b. by mass
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balance) which were used to prepare the protein fragments. The optimal conditions to
accomplish the Alcalase enzymatic hydrolysis of the proteins in order to derive peptides of
varying sizes were achieved using a statistical design for a 30 % degree of hydrolysis to derive
protein hydrolysates or peptides of varying sizes (Rayaprolu et al., 2013). The ultrafiltration of
GI-resistant protein hydrolysates using molecular cut-offs columns—5, 10 and 50kDa provided
the fractions <5, 5-10, 10-50 and >50kDa (yield: 1.8–2.1 % d. b. by mass balance, derived from
the isolate) for each soybean line with protein content ranging between 89 and 92 %. Initial
screening showed comparatively poor ACE-I inhibition by the >50kDa fractions which were
eliminated during further testing. The non-GI fractions showed overall low ACE-I inhibition
when compared to the GI fractions which was in agreement with previous research (Kannan,
2009).
A concentration of 500 μg/mL was used for the study where the results showed overall
low activity in comparison to the positive control, captopril (approximately 75 % inhibition).
However, the highest inhibition among the fractions was 48.9% by the 5-10kDa obtained from
R95-1705 soybean line (Figure 4.2), and this fraction was chosen for the dose response study to
determine the minimum inhibitory concentration. The <5-kDa fraction from the high oleic acid
soybean line N98-4445A showed an inhibition of 42.2 ± 1.3 % which was the only other
significant activity observed against the ACE-I enzyme among all the protein hydrolysate
fractions. Peptides of both large and small sizes have shown bioactivities in previous studies and
have exhibited functionalities that can be used in food products (Wu et al., 1998, Wu and Ding,
2002). The hydrolysates tested for GI resistance could potentially be available for absorption
through the intestine when consumed as food and elicit the health beneficial bioactivities in the
target tissues. Researchers have shown that peptides of various molecular sizes are absorbed

86

through the intestinal wall but the ability of absorption decreases with an increase in molecular
size (Roberts et al., 1998).
Dose response study of the fraction with highest activity and purification using
chromatography
A dose response study of the 5-10kDa fraction (R95-1705) revealed an increase in ACE-I
inhibitory activity as the dosage of the fractions increased (Figure 4.3). The highest inhibition
was achieved at 1200 μg/mL concentration (75.5 ± 2.8 %) which was not significantly different
from that shown by 1000 μg/mL concentration (72.4 ± 1.4 %). An increase in ACE-I inhibition
was observed at ≥800 μg/mL concentration, although the highest inhibition by the fractions was
significantly lower in comparison to the positive control. The dose response provided the
inhibitory concentration at 50 % activity (IC50) of the 5-10kDa protein fraction from R95-1705
to be 563 μg/mL. These results are significant as R95-1705 is a non-GM soybean line, which can
have a potential impact on its utilization in foods or supplemental therapeutics. The ACE-I
inhibitory activity can be attributed to the pool of peptides from 5-10kDa and their amino acid
sequences. However, other studies have reported significant ACE-I inhibitory activity by similar
molecular size peptide fractions which were derived from marine protein sources (Lee et al.,
2010). Previous studies from the current research group have shown the ability of large
molecular size peptide fractions (>50 kDa) to have ACE-I inhibition (Lassissi et al., 2014).
Researchers have also reported ACE-I and atherosclerosis inhibition by hydrolysates obtained
from both glycinin and β-conglycinin fractions of soy protein (Kuba et al., 2005, Adams et al.,
2004). Hence, the peptide fraction from R95-1705 (5-10kDa) with anti- ACE-I activity may have
been derived from either the glycinin (11S) or β-conglycinin (7S) fractions of the proteins which
needs further examination.
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Several factors can be attributed to the substantial anti-ACE-I activity that can be studied,
starting with the purification of the peptide pool from the 5-10kDa fraction from R95-1705
soybean line. The HPLC analysis of the peptide fraction showed 5 individual peptides which
were separated by the elution time on the column (Figure 4.4). The solvent system and the
gradient used were efficient in separating the 5 peptides in the fraction.
Studies have also shown that protein hydrolysates and peptides derived from various food
sources possess anti-ACE-I activities (Lee et al., 2010, Balti et al., 2010, Lassissi et al., 2014).
Although most researchers tested (pure) peptides derived from either fermentation or enzymatic
hydrolysis, very few studies have demonstrated the bioactivity of GI-resistant protein
hydrolysates which contain a pool of peptides. Preparation of hydrolysates is economical in
comparison to derivation of pure peptides. Peptide fractions can provide synergistic effects and
have shown multiple bioactivities (Kannan et al., 2008, Rayaprolu et al., 2013).

Conclusion
The protein fraction from the R95-1705, a non-GM soybean, showed highest ACE-I inhibition.
This is the first time ACE-I inhibition has been achieved with GI-resistant non-GMO soy protein
hydrolysates derived by enzymatic digestion of high purity protein isolates. The 5-10kDa protein
fraction at a higher dose presented an enhanced ACE-I inhibitory activity. In conclusion, this
study provides amino acid composition of soybean lines that are grown for definite yield
attributes and demonstrates functional activity of protein/peptide fractions derived from selected
soybean lines.

88

References
Adams MR, Golden DL, Franke AA, Potter SM, Smith HS, Anthony M. S. 2004. Dietary soy βconglycinin (7S globulin) inhibits atherosclerosis in mice. J Nutr 134(3): 511–516.
Adler-Nissen, J. Enzymatic hydrolysis of food proteins; Elsevier Applied Science Publishers:
London, 1986.
Adler-Nissen, J. Proteases. 1993. In: Enzymes in food processing; Nagodawithana T, Reed zg.
Eds.; Academic press: San Diego, pp. 159-203.
Balti R, Nedjar-Arroume N, Bougatef A, Guillochon D, Nasri M (2010) Three novel angiotensin
I-converting enzyme (ACE-I) inhibitory peptides from cuttlefish (Sepia officinalis) using
digestive proteases. Food Res Int 43(4): 1136–1143.
Boudier, H. S., Le Noble, J. L., Messing, M. W., Huijberts, M. S., Le Noble, F. A. and van
Essen, H. 1992. The microcirculation and hypertension. J Hypertens, 10(Suppl): S147-S156.
Cushman D. W. and Cheung H. S. 1971 Spectrophotometric assay and properties of the
angiotensin-converting enzyme of rabbit lung. Biochem Pharmacol, 20(7): 1637–1648.
Kannan A., Hettiarachchy N. S., Johnson M. G., and Nannapaneni R. 2008. Human colon and
liver cancer cell proliferation inhibition by peptide hydrolysates derived from heat-stabilized
defatted rice bran. J Agric Food Chem, 56: 11643–11647.
Kannan A. 2009. Preparation, separation, purification, characterization and human cell line
anticancer evaluation of rice bran peptides. Ph. D. dissertation submitted to University of
Arkansas.
Kannan, A., Hettiarachchy, N. S., Lay, J. O. and Liyanage, R. 2010. Human cancer cell
proliferation inhibition by a pentapeptide isolated and characterized from rice bran. Peptides,
31(9), 1629-1634.
Kuba M, Tana C, Tawata S, Yasuda M (2005) Production of angiotensin I-converting enzyme
inhibitory peptides from soybean protein with Monascus purpureus acid proteinase. Process
Biochem 40(6): 2191–2196.
Lassissi TA, Hettiarachchy NS, Rayaprolu SJ, Kannan A, Davis M (2014) Functional properties
and Angiotensin-I converting enzyme inhibitory activity of soy–whey proteins and fractions.
Food Res Int 64: 598–602.
Lee S-H, Qian Z-J, Kim S-K (2010) A novel angiotensin I converting enzyme inhibitory peptide
from tuna frame protein hydrolysate and its antihypertensive effect in spontaneously
hypertensive rats. Food Chem 118(1): 96–102.

89

Leppälä A. P. 2000. Bioactive peptides derived from bovine whey proteins: opioid and ACEInhibitory peptides. Trends Food Sci Technol, 11(9–10): 347–356.
Ma A. Y. M. and Ooraikul B. 1986. Optimization of enzymatic hydrolysis of canola meal with
response surface methodology. J Food Process and Preserv, 10(2): 99-113.
Mahmoud M. I., Malone W. T. and Cordle C. T. 2006. Enzymatic Hydrolysis of Casein: Effect
of Degree of Hydrolysis on Antigenicity and Physical Properties. J Food Sci, 57: 1223-1229.
Margatan W, Ruud K, Wang Q, Markowski T, Ismail B (2013) Angiotensin converting enzyme
inhibitory activity of soy protein subjected to selective hydrolysis and thermal processing. J
Agric Food Chem 61(14): 3460–3467.
Nielsen PM, 1997. Functionality of protein hydrolysates. Ch 15 in “Food proteins and their
applications” edited by Damodaran A., Paraf A. Marcel Dekker Inc., New York, NY, USA.
Nielsen, P. M., Petersen, D. and Dambmann, C. 2001. Improved method for determining food
protein degree of hydrolysis. J Food Sci, 66(5): 642-646.
Obata A, Hosoyama H, Ogawa T 1998. Development of Tofu-like product from soy milk for
soybean-sensitive patients. Shokuhin Kogya (in Japanese), 41: 39-48.
Okezie B. O. and Bello A. B. 1988. Physicochemical and Functional Properties of Winged Bean
Flour and Isolate Compared with Soy Isolate. J Food Sci, 53(2): 450-454.
Palatini P, Julius S. 2009. The role of cardiac autonomic function in hypertension and
cardiovascular disease. Curr Hypertens Rep, 11(3): 199–205.
Rayaprolu SJ, Hettiarachchy NS, Chen P, Kannan A, Mauromostakos A (2013) Peptides derived
from high oleic acid soybean meals inhibit colon, liver and lung cancer cell growth. Food Res Int
50(1): 282–288.
Roberts PR, Burney JD, Black KW, Zaloga GP (1998) Effect of chain length on absorption of
biologically active peptides from the gastrointestinal tract. Digestion 60(4): 332–337.
Shih F. F., Daigle K.1997. Use of enzymes for the separation of protein from rice flour. Cereal
Chem. 74: 437-441.
Tang S, Hettiarachchy N. S, Shellhammer T. H 2002. Protein extraction from heat-stabilized
defatted rice bran. 1. Physical processing and enzyme treatments. J Agric Food Chem, 4;
50(25):7444-8.
Wu, J. and Ding, X. 2002. Characterization of inhibition and stability of soy-protein-derived
angiotensin I-converting enzyme inhibitory peptides. Food Res Int, 35(4): 367–375.

90

Wu WU, Hettiarachchy NS, Qi M (1998) Hydrophobicity, solubility, and emulsifying properties
of soy protein peptides prepared by papain modification and ultrafiltration. J Am Oil Chem Soc
75(7): 845–850.
Yamanishi R, Tsuji H, Bando N, Yamada Y, Nadaoka Y, Huang T, Nishikawa K, Emoto S,
Ogawa T 1996. Reduction of the allergenicity of soybean by treatment with proteases. J Nutr Sci
Vitaminol, 42: 581-587.

91

Figure 4.1. The prediction profiler of the JMP showing the optimized conditions. (DH=degree of
hydrolysis, Enz=Enzyme concentration). (Rayaprolu et al., 2015).
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Figure 4.2. The ACE-I inhibitory activity of soybean peptide fractions at 500µg/mL
concentration. Values are means ± standard deviation. Bars not connected wtih same letter are
significantly different (P <0.05). (Rayaprolu et al., 2015).
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control. Negative Ctrl – 1.0% saline. Bars are means ± standard deviation and those not
connected with same letter are significantly different (P<0.05). (Rayaprolu et al., 2015).
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Figure 4.4. Purification of the 5-10kDa peptide fraction from R95-1705 using HPLC
method. The arrow heads represent 5 individual peptides present in the 5-10kDa fraction which
showed combined activity against ACE-I. (Rayaprolu et al., 2015).
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Table 4.1. Types of proteases and specificity of these enzymes used for protein hydrolysis in
general (Adler-Nissen 1993).
Enzyme
Type of protease Specificity
Liquipanol
Bromelain
Alcalase

Cysteine
Cysteine
Serine

Protex 6L
Trypsin and Chymotrypsin
Carboxypeptidase

Serine
Serine
Metallo

Broad
Broad, prefers Arg-Arg peptides
Broad, prefers uncharged residue’s
carboxyl site
Broad for peptide bonds
Lys, Arg, Phe, Trp, Tyr, Ala
Terminal amino acids at C-terminus
with exceptions: Pro, Arg, Lys
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Table 4.2. Protein content (purity) in the isolate extracted from three soybean lines (N98-4445A,
R95-1705 and S03-543CR).
Soybean line

Protein % (dry basis)

S03-543CR
N98-4445A
R95-1705

90.82 ± 0.61a
91.6 ± 0.95a
93.34 ± 1.29b

Values (means ± standard deviation) not connected with same letters are significantly different
(P<0.05). (Rayaprolu et al., 2015).
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Table 4.3. The Box-Behnken design of the surface response method to determine the
optimal degree of enzymatic hydrolysis.
S.No Pattern Enzyme pH Time (min) Temperature (°C)
1
−−−−
1
6.5
30
55
2
−−−+
1
6.5
30
70
3
−−+−
1
6.5
90
55
4
−−++
1
6.5
90
70
5
a000
1
7.5
60
62.5
6
−+−−
1
8.5
30
55
7
−+−+
1
8.5
30
70
8
−++−
1
8.5
90
55
9
−+++
1
8.5
90
70
10
0a00
3.5
6.5
60
62.5
11
00a0
3.5
7.5
30
62.5
12
000a
3.5
7.5
60
55
13
0
3.5
7.5
60
62.5
14
0
3.5
7.5
60
62.5
15
000A
3.5
7.5
60
70
16
00A0
3.5
7.5
90
62.5
17
0A00
3.5
8.5
60
62.5
18
+−−−
5
6.5
30
55
19
+−−+
5
6.5
30
70
20
+−+−
5
6.5
90
55
21
+−++
5
6.5
90
70
22
A000
5
7.5
60
62.5
23
++−−
5
8.5
30
55
24
++−+
5
8.5
30
70
25
+++−
5
8.5
90
55
26
++++
5
8.5
90
70
The pH, time, temperature and enzyme concentration (Enz) are the independent variables,
each with three levels. The column S. No. shows the number of experimental runs while
‘Pattern’ column shows the design for each experiment where ‘-‘stands for the lowest level, ‘0’
is for the middle and ‘+’ is for the highest level for each variable.
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CHAPTER 5
Peptides Derived from High Oleic Acid Soybean Meals Inhibit Colon, Liver and Lung
Cancer Cell Growth
(Part of the chapter published in Food Research International Journal, 50: 282-288.)

Abstract
Soybean meal, a co-product after oil extraction from seeds, is rich in protein. Our objective was
to utilize this co-product, obtain gastrointestinal (GI) resistant peptides from the isolated protein,
and test for bioactivity against colon, liver and lung cancer cell lines. N98-4445A, S03-543CR
high oleic acid soybean lines, and R95-1705 high protein soybean line were used for this study.
Protein isolates were prepared at alkaline pH and hydrolyzed using Alcalase enzyme to generate
peptide hydrolysates. After determining gastrointestinal resistance of the peptide hydrolysates
they were fractionated into definite molecular sizes of <5 kDa, 5-10 kDa, and 10-50 kDa and
tested against human colon (HCT-116, Caco-2), liver (HepG-2) and lung (NCL-H1299) cancer
cell lines. MTS, 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)2H-tetrazolium) cytotoxicity assay was performed to test in vitro cancer cell viability upon
treatment with peptide fractions. The peptide fractions from N98-4445A and S03-543CR lines
showed cell growth inhibition of 73 % of colon cancer (HCT-116), 70 % of liver cancer cells and
68 % of lung cancer cells. Dose response showed that the peptides had significant inhibitory
effect at higher concentrations (1000 µg/mL to 600 µg/mL) and gradually decreased with
decreased dosage (500 µg/mL to 100 µg/mL). Soybean peptide fractions can thus be a source of
bioactivity against colon, liver and lung cancer cell proliferation.

99

Introduction
Soybeans are grown for commercial edible oil, and among the genetic lines the high oleic
acid (HOA) lines are in demand from the industry due to high oleic to linolenic acid ratio that is
more stable in food products (USDA 2009). The HOA soy lines have genetically manipulated
fatty acid content in the seeds with higher amounts of mono-unsaturated oleic acid as a substitute
for poly-unsaturated linoleic acid (Cahoon, 2003 and Hyten et al., 2004). High oleic acid oil
causes low rancidity in the foods prepared with the soybean oil, giving them a longer shelf life.
Studies have also shown an increase in essential amino acid, lysine in the hybridized high oleic
acid soybean seeds compared to the parents (Kinney, 2007). This is an essential criterion since
the residue after oil extraction from the seeds, soy meal, is a rich source of protein with the
essential amino acids except for the sulfur containing amino acid methionine. Soybean protein is
an excellent healthy substitute for animal protein and is used as a protein supplement in muscle
building. While processed animal meats are known to cause health concerns including cancer
and heart disease due to the presence of nitrosamines, soy protein has been proved to promote
health without causing any detrimental health conditions (Norat et al., 2001).
Cancer is the second leading cause of death in the United States after heart disease. The
Centers for Disease Control and Prevention has claimed an estimated 577,190 cancer deaths in
2012 (ACS, 2012). Approximately 1.6 million new cancer cases were to be diagnosed of which
approximately 9 % are colorectal and approximately 29,000 new cases of liver and related
organs are expected in 2012. According to American Cancer Society an estimated 14 % of
cancer diagnoses in 2012 are related to lung and bronchus while, colorectal cancer is ranked third
among all cancer deaths in the United States (ACS, 2012). Treatment of cancer is highly
expensive involving drugs that have adverse side effects and toxicity complications. Cheaper
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alternative methods using bioactive peptides can have better prospects in the economics of
cancer prevention and therapy. These bioactive peptides are derived from food ingredients and
are acceptable due to their non-toxic nature (Silva-sanchez et al., 2008). Bioactive peptides from
food sources like egg protein and milk protein with health promoting properties have been
studied extensively in the recent years (De Mejía and De Lumen, 2006). Peptides from fermented
soy products including Tempeh and Natto (Gibbs et al., 2003) and those formed after enzymatic
digestion of protein from soybeans and rice bran have shown bio-activity against cancer (Zang et
al., 1998; Kannan et al., 2008). Researcher also studied peptides derived from bacterial
fermentation of milk to determine their bioactivity (Algaron et al., 2004). However, no literature
information on bioactivity is available on protein or peptides derived by enzymatic hydrolysis
from high oleic acid soybean meals.
The primary objective of this research was to derive peptides from the soybean meal of
high oleic acid soybean lines N98-4445A and S03-543CR and compare the cell proliferation
inhibition with that of the peptides prepared from a high protein soybean line R95-1705.
Alcalase enzyme was used to hydrolyze the isolated protein, since it is extensively studied and
used in the industry (Gupta et al., 2002). In this study, peptide hydrolysates were prepared from
high oleic acid soy protein isolates (SPIs), tested for gastrointestinal resistance, fractionated
based on molecular size, and tested for multiple site cancer inhibiting activities.

Materials and methods
Preparation of Protein Isolate and Enzymatic Hydrolysis to Derive Gastro‑Intestinal
Resistant Peptide Fractions
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Seeds from the three selected (based on high protein content) soybean lines (high oleic acid:
N98-4445A, S03- 543CR; high yield: R95-1705) were ground, defatted and passed through a 60mesh (250 μm particle size) sieve. Suspensions of the flours were prepared to extract the protein
at an alkaline pH of 9.5 precipitated at isoelectric pH of 4.5 to obtain the protein isolates. The
protein isolates were digested using the enzyme Alcalase 2.4L under optimal conditions to derive
varying size protein hydrolysates (Rayaprolu et al., 2013). The hydrolysates were then passed
through a simulated gastro-intestinal (GI) environment using the enzymes, pepsin and
pancreatin, at 37 °C to derive GI-resistant protein hydrolysates. Ultrafiltration molecular cut-off
membrane columns were used to collect the peptide fractions, <5, 5–10 and 10–50kDa, which
were freeze-dried and stored at 4 °C.
Cell proliferation inhibition assay against human cancer cell lines and dose and time
response study
The GI resistant peptide hydrolysates were tested on human cancer cell lines and normal
human colon and lung cell lines for toxicity. The Caco-2 (ATCC number: HTB-37), HCT-116
(ATCC number: CCL-247) colon epithelial cancer cells and CCD-18Co normal colon fibroblast
cells (ATCC number: CRL 1459); HepG-2 (ATCC number: HB-8065) liver epithelial cancer
cells; NCL-H1299 (ATCC number: CRL-5803) lung cancer cells and LL 47 (MaDo) normal
lung fibroblasts (ATCC number: CCL-135); and the culture media were purchased from ATCC
(Manassas, VA, USA). The cell lines were cultured in 25 cm2 flasks by adding 10mL of media
and incubating at 37 °C with 5% CO2 for 24 - 48 hours. Stock cultures were prepared
(approximately between 200,000 to 2,000,000 cells) by trypsinizing the monolayer of cells with
3 mL of Trypsin-EDTA reagent (0.1% Trypsin + 0.53mM EDTA solution).
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The prepared stocks were used to culture the cells in 25 cm2 flasks, trypsinized and
transferred to 96-well tissue culture plates with fresh media and incubated at 37 °C with 5% CO2
for 48 hr. The peptide fractions in solution (800 µg/mL) were added to the wells along with fresh
media and the plates were incubated at 37 °C with 5% CO2 for 24-36 hours. For the dose
response study, 10-50 kDa peptide fractions from N98-4445A soy line were prepared with
varying concentrations ranging from 100 g/mL to 1000 g/mL and compared with 200 g/mL
Genistein. The plates were observed for disruption of the mono layer over a period of 18 to 72
hours. The 3-(4, 5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2Htetrazolium) (MTS) (Promega Inc., Madison, WI, USA) assay was conducted to determine the
cell growth inhibition by the peptides. Wells untreated were considered as the negative control
and the test was done in triplicate for all cell lines. The mitochondria of the live cells metabolize
the MTS reagent and form a soluble substance called Formazan. The amount of formazan
liberated in solution formed by the cancer cells was used to determine the number of live cells by
measuring the absorbance at 490 nm in a micro plate reader (Bio-Rad Inc., Hercules, CA, USA).
The % inhibition of the cancer cell proliferation by the GI resistant peptide fractions were
calculated as:
% Inhibition = 1 – [(AbsTest - AbsNegCtl)/(AbsPosCtl - AbsNegCtl)] * 100
Where, AbsTest = absorbance of the test sample, AbsNegCtl = absorbance of the negative control,
and AbsPosCtl = absorbance of positive control (Genistein).
The hydrolysate with highest inhibitory activity was also tested for cell toxicity using the
MTS assay against normal human colon cell line. The dose response test was conducted for the
fraction with highest activity against cancer cell proliferation at a dosage ranging from 100 to
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1000 g/mL. This was used to calculate the minimum effective concentration of the peptide
fractions against the cancer cells.
Statistical analysis
The Student’s t test with JMP software from SAS institute (Cary, NC) was used for the statistical
analyses: analysis of variance, means and standard deviations (P value <0.05).

Results and discussion
Preparation of GI resistant peptide fractions under optimal conditions
Protein extraction under alkaline conditions yielded highest purity (91-93%) as per
previous research (Okezie and Bello, 1988). The Box-Behnken RSM statistical design was
effective in evaluating the optimal conditions for enzymatic hydrolysis of protein isolates from
the three soybean lines based on degree of hydrolysis. A DH of 30 % was selected as the
optimum condition at pH 7, enzyme concentration of 1.675 AU, temperature of 55 °C for 45 min
to derive high and low molecular weight protein fractions. This allowed for formation of
considerable size peptides that can resist complete digestion when exposed to the gastrointestinal juices.
Peptides of varying sizes were shown to provide functionality in food products (Wu et
al., 1998, Wu and Ding 2002). The resistance to GI juices by the peptides demonstrated the
potential for getting absorbed through the intestinal lining and to elicit tissue level functional
properties. Ultrafiltration technology proved adequate for separating the GI resistant peptides
based on their molecular sizes. The three membrane size cut-offs, <5 kDa, 5-10 kDa and 10-50
kDa, from each soy line were collected to test the cancer cell inhibitory property.
Inhibition of cancer cell proliferation
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Colon cancer cell growth inhibition (Caco-2 and HCT-116)
Two colon cancer cell types were chosen to test the effectiveness of the peptide fractions
derived from the three soy meals. While Caco-2 represents cells derived from cancerous colon,
HCT-116 represents a colon with tumorigenic pathology. The Caco-2 cells showed slower
growth in vitro (24 to 48 hr) when compared to HCT-116, HepG-2 and NCL-H1299 cell lines
(18 to 24hr) which was based on the rate of mono layer formation. The high molecular sized
fractions (10-50 kDa) from S03-543CR line showed 50% inhibition on Caco-2 cancer cells
(Figure 5.1) which was not significantly different from that of the low molecular weight <5 kDa
fractions from N98-4445A, while the positive control inhibited 63% of the cancer cells . The
highest inhibitory activity on Caco-2 cells was documented by the <5 kDa peptide fractions of
N98-4445A soy line (54%) which was not significantly different from that of 10-50 kDa
fractions of the S03-543CR line (50 %) (Figure 5.1). The 10-50 kDa fractions from N98-4445A
4445A inhibited 73% of the HCT-116 cancer cells and this was statistically significant when
compared to the positive control (77% inhibition). Figure 5.2 shows the activity of the peptide
fractions on HCT-116 where <5kDa fraction from R95-1705 showed the only other significant
inhibition. Even though the inhibition of Caco-2 cancer cells by the soy peptides was not
statistically comparable to that of genistein, a 50% or more inhibition of the cancer cells is a
significant amount of bioactivity against colon cancer growth. This significant inhibitory activity
of the GI resistant hydrolysates against both cancer cell lines has potential use in restricting the
malignancy of the disease.
Liver cancer cell growth inhibition (HepG-2)
The 10-50 kDa fractions of N98-4445A and S03-543CR soybean lines at a concentration
of 800 μg/mL inhibited approximately 70% of HepG-2 cells which was not significantly
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different from that of the positive control Genistein at 200 μg/mL (Figures 5.3). The <5 kDa
fractions from N98-4445A line also showed significant inhibition of 64% which was similar to
that of the positive control as per the statistical analysis. The inhibitory effect of the other peptide
fractions was not statistically significant at a P value of <0.05 for the <5 kDa fractions from R951705.
Lung cancer cell growth inhibition (NCL-H1299)
On the NCL-H1299 lung cancer cells, the <5kDa fractions from N98-4445A and 510kDa fractions from S03-543CR showed 68% inhibition which was statistically comparable
with the 73% inhibition of cell growth by the positive control Genistein. The 10-50kDa fractions
from the high oleic acid soybean lines N98-4445A and S03-543CR also showed 50% and 47%
inhibition of the lung cancer cells respectively, which was significantly lower than that of the
smaller size fractions (Figure 5.4).
Dose response study on the inhibition of HCT-116 colon cancer cell growth
Even though the smaller peptide fractions had shown cell proliferation inhibition, the
overall results from the study show that the 10-50kDa peptide fractions from the high oleic acid
soybean lines N98-4445A and S03-543CR and had a significant inhibiting effect on both colon
and liver cancer cell lines. A statistically significant inhibitory effect was demonstrated by the
high oleic acid soybean peptide fractions although, dose used in the study were four times that of
the positive control. Dose response study of the most effective (73% inhibition) 10-50kDa
peptide fractions of N98-4445A soybean line showed that the inhibition of cancer cells was
consistent at higher concentrations of 1000 μg/mL to 600 μg/mL on HCT-116 colon cancer cells
and decreased to insignificant levels when the concentrations lowered from 500 μg/mL to 100
μg/mL (Figure 5.5). This test also showed that at the highest dosage level the cancer cell
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inhibition was higher than that of the anticancer agent, Genistein, at 200 μg/mL. The minimum
effective concentration of genistein (200 ug/mL) was used as a positive control for comparison
that showed highest inhibitory activity. Beyond this dose, clumping of cells was observed,
limiting effective counting of cells. Most effective inhibition of all the cancer cells tested
occurred during 36 and 48 hours of incubation with the protein hydrolysates. The IC50 value,
which demonstrates the concentration of the hydrolysate where the cancer cell population is
reduced by half, was 0.39 mg. The Analysis of Variance for the dose response on the HCT-116
colon cancer cells study showed an F ratio of 379.9 which was significant at <0.0001 (R2 = 0.99)
and the Student’s T test value was 2.10 (α = 0.05). The analysis also demonstrated that there was
no significant difference in the activity between 400 µg and 500 µg doses while a 600 µg dose is
the minimum inhibitory concentration required to achieve a significant inhibition of the colon
cancer cell population.
Toxicity study of the most effective anticancer hydrolysates
The hydrolysates from all three soybean lines were tested for toxicity on normal human
colon (CCD-18Co) and lung (LL 47 (MaDo)) cell lines. The MTS cell proliferation inhibition
assay showed zero toxicity of the peptide hydrolysates which was comparable to negative control
(media only) for both the cells.

Conclusion
Preparation of protein isolate from the meals helped in removal of extraneous matter
including starch, and provided protein with high purity for hydrolysis with Alcalase. Gastrointestinal resistance test showed that the peptide fractions can remain active when consumed.
The high inhibition percentage of the high oleic acid lines could have possibly been due to the
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amino acid make-up, sequence and the terminal residues of these smaller peptide fractions. The
results were conclusive of the hypothesis that bioactive cancer inhibiting peptide fractions can be
derived from enzymatic hydrolysis of the isolated soybean protein. The present study has
significance since the peptides with cancer cell inhibiting activity can add value to oil separated
meal from high oleic acid soybean lines. Cancer cell inhibiting peptides have been produced
from high oleic acid soybean lines, N98-4445A and S03-543CR for the first time in this study
with a possibility of generating substantial economic value to the soybean growers. It could be
concluded that peptide fractions derived from meals of high oleic acid soybean lines have the
property of inhibiting cancer cell growth in human cell lines and could have potential
nutraceutical use against colon, liver and lung cancers.
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Figure 5.1. Caco-2 colon cancer cell line growth inhibition by gastro-intestinal resistant
peptides from the three soybean lines. Positive control: Genistein 200 µg/ml, Negative control:
Culture media only. Values (means ± standard deviation) not connected with same letters are
significantly different (P<0.05). (Rayaprolu et al., 2013).
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Figure 5.2. HCT-116 colon cancer cell line growth inhibition by GIPs from the three
soybean lines. Positive control: Genistein 200 µg/ml, Negative control: Culture media only.
Values (mean ± standard deviation) not connected with same letters are significantly different
(P<0.05). (Rayaprolu et al., 2013).
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Figure 5.3. HepG-2 Liver cancer cell line growth inhibition by GIPs from the three soybean
lines. Positive control: Genistein 200 µg/ml, Negative control: Culture media only. Values
(means ± standard deviation) not connected with same letters are significantly different (P<0.05).
(Rayaprolu et al., 2013).
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CHAPTER 6
Bioactivity of soybean protein fractions against human blood, breast and prostate cancer
cell lines

ABSTRACT
In this study, we examined in vitro bio-activity of the peptide fractions against blood (CCRFCEM and Kasumi-3), breast (MCF-7), and prostate (PC-3) cancer cell proliferation. Gastrointestinal resistant peptide fractions (<5, 5-10 and 10-50kDa) prepared from seed proteins of two
high oleic acid soybean lines - N98-4445A, S03-543CR and one high protein line - R95-1705,
were tested for anticancer activity against human breast, blood and prostate cancer cell lines.
Anti-proliferative cell titer assay was conducted to assess the inhibitory effects of the peptide
fractions, while Trypan blue dye exclusion assay was used to determine the dose response of
most effective fractions. Results showed that the peptide fractions inhibited the cancer cell lines
up to 68% and the minimum inhibitory concentration ranged between 608-678 µg/mL. This
multiple site in vitro cancer inhibition by GI friendly peptides could have potential use in food
ingredients or nutritional supplements in alternative cancer therapy.
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Introduction
The use of alternative methods in treating diseases like cancers has been on the rise in
recent years. Conventional treatment methods like radiation and chemotherapy have become
highly expensive and involve adverse side effects. Advanced cancer treatment methods employ a
holistic approach by incorporating dietary or nutritional, spiritual and physical therapies along
with drugs and radiation. As part of nutritional supplementation, bioactive peptides have a
prominent role in alternative medicine which involves controlling diseases using food derived
macro molecules (Zhang et al., 1998, Korhonen & Pihlanto, 2003, Kannan et al., 2008). Certain
other bioactive molecules are from natural sources like plants (Ng 2003, Ohba et al., 2004, SilvaSánchez 2008). One of the major approaches to produce bioactive peptides was enzymatic
hydrolysis or fermentation, especially from sources like soybean, wheat, corn, rice, sunflower,
milk, eggs, and meat (Wang and de Mejia, 2005, De Mejia, 2006, Gibbs et al., 2004).
Although it is used as a low cost animal feed, the potential nutritive nature, especially of
the protein obtained from soybean meal components is well documented (Gallagher et al., 2004).
With studies conferring bioactivities to proteins, we found it necessary to test soybean protein
hydrolysates for reducing the risk of cancer disease on cell culture models. Soybean meal has
≥45% protein with possible unique amino acid types and sequence that could render bioactive
nature by mitigating apoptosis in cancer cells (Hernandez-Ledesma et al., 2009, Hsieh et al.,
2010). It is also of significant importance for the bioactive peptides to possess resistance to
gastrointestinal environment when ingested. Soy has several value-added uses and has proven to
be a source of peptides derived by enzymatic hydrolysis that have shown nutraceutical and
functional properties (Rayaprolu et al., 2013). However, studies are lacking on the effect of
peptides from high oleic acid lines on cancers like blood (leukemia), breast and prostate, which
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are estimated to cause a total of 94,000 deaths (2014) in the United States (ACS 2014). This is
the first study that utilized high oleic acid soy meal as a starting raw material to produce peptides
with anticancer activity against breast, blood and prostate cancers that can have a significant
impact in their treatment. Our previous studies have shown anticancer activities against colon,
liver and lung cancer cells (Rayaprolu et al., 2013). The present study is in continuation to
evaluate anti-proliferative activity against blood (CCRF-CEM, Kasumi-3), breast (MCF-7) and
prostate (PC-3) cancer cell lines. Utilization of a low cost soybean meal to produce effective
anticancer peptides is the significant achievement of this research. The objectives of this research
were to select two high oleic acid and one high protein soybean lines to prepare peptides, prepare
protein hydrolysates with enzyme Alcalase under optimum conditions, treat peptides with
simulated gastro-intestinal juices, fractionate the peptides using ultrafiltration and investigate the
anticancer activity of GI resistant fractions on the human blood, breast and prostate cancer cell
lines.

Materials and Methods
Seeds from three soybean lines, S03-543CR and N98-4445A (high in oleic acid) and
R95-1705 (high in protein, non-transgenic) were provided by Dr. Pengyin Chen (Professor, Plant
Sciences Department, University of Arkansas). Food grade enzyme, Alcalase, was purchased
from Novozyme Inc. (Bagsvaerd, Denmark) and gastro-intestinal enzymes pepsin and pancreatin
were purchased from Sigma-Aldrich (St. Louis, MO). The ultrafiltration system was purchased
from Koch membrane systems (Massachusetts, USA). The cell lines and media were obtained
from ATCC (Manassas, VA) and Fetal Bovine Serum was purchased from Atlanta Biologicals
(Altlanta, GA, USA). The reagents for cell proliferation inhibition were purchased from Sigma-
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Aldrich (St. Louis, MO) and Promega Inc. (Madison, WI). The cells were observed for
morphological changes using a Vistavision inverted phase contrast microscope (VWR, West
Chester, PA). All other chemicals and supplies were obtained from VWR (West Chester, PA).
Inverted phase contrast microscope was purchased from (VWR Inc., West Chester, PA).
Preparation of Enzyme-Treated Soy Protein Hydrolysates.
The soybean seeds were ground to flour and sieved (250 μm) for uniform particle size.
The lipid was removed using the solvent, N-hexane, to collect the residue which is called the
soybean meal. The meals were suspended in water (10% w/v) and protein was isolated at an
alkaline pH of 9.5 under ambient temperature conditions. The protein was separated from
solution using isoelectric pH (4.5) as described previously (Rayaprolu et al., 2013) and the
isolates obtained with ~90% purity were then freeze dried and stored at 5 0C.
The protein isolates were suspended in water (10% w/v), mixed to homogeneity, the pH
was adjusted to 7.0 and incubated at 55 ºC. These isolates were treated with the enzyme Alcalase
(at a concentration of 1.675 Anson units) for 1 hour based on the optimal conditions for a 30%
degree of hydrolysis using the Box-Behnken Design of the Response Surface Methodology
(Diniz & Martin, 1996, Rayaprolu et al., 2013). The enzyme was inactivated at a temperature of
90 °C, and hydrolysates were separated by centrifugation, freeze dried and stored at 5 ºC.
Preparation of Gastrointestinal (GI) Juice Resistant Soy Peptide Fractions.
The enzyme treated hydrolysates were passed through a simulated gastric and intestinal
solution as previously described (Rayaprolu et al., 2013). The GI-resistant protein hydrolysates
were fractionated using Ultrafiltration system equipped with 1" diameter hollow-fiber
polysulfone membrane cartridges. Nominal molecular weight cut-offs (MWCO) of 50, 10, and 5
kDa sequential ultrafiltration columns were used. The filtered soluble GI-resistant protein
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hydrolysates were passed through the columns as the retentates and permeates were collected
separately for each soybean line. Approximately a quarter of the total volume of protein
hydrolyates were obtained which are now addressed as GI-resistant peptide fractions (<5kDa, 510kDa and 10-50kDa). The nine molecular cut-off fractions from the three soybean lines (3
soybean lines X 3 fractions) were freeze-dried and were tested for inhibitory activity against
human blood (CCRF-CEM and Kasumi-3) and breast (MCF-7) and prostate (PC-3) cancer cell
lines.
Propagation of Human Cancer Cell Lines.
Human prostate cancer cell line PC-3 (ATCC# CRL-1435) was cultured in F-12K
medium, Kasumi-3 (ATCC# CCL-2725) and CCRF-CEM (ATCC# CCL-119) blood cancer cell
lines were cultured in RPMI-1640 medium, and the breast (epithelial) cancer cell line MCF-7
(ATCC# HTB-22) was cultured in Eagle’s Minimum Essential Medium. The peripheral blood
cells (ATCC# PCS-800-010) were cultured in the recommended Hank's Balanced Salt Solution
and used for toxicity tests. All the media were devoid of antibiotics and supplemented with 10%
fetal bovine serum. The cells were incubated at 37 °C Cells in a humidified atmosphere
containing 5% carbon dioxide. The growth phase of all cancer cells was monitored using an
inverted phase contrast microscope. After cell growth achieved 80%, they were treated with the
peptide fractions, <5kDa, 5-10kDa and 10-50kDa, from the three soybean lines. The antiproliferation assay was performed to determine the anticancer activity.
Determination of Anti-Proliferative Activity of the Peptides - MTS Colorimetric Assay.
The [3-(4,5- dimethyl thiazole-2-yl)]-2,5-diphenyl tetrazolium bromide (MTS)-based cell
titer assay was used to determine the effect of soybean peptide fractions on the cytotoxicity
against cancer cells.. The blood cancer cell lines, CCRF-CEM and Kasumi-3, were allowed to
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grow in suspension (medium) since they do not attach to the well surface. Fresh growth media
was added by separating the cells using centrifugation (1000 x g for 5 min). The pellet was
rinsed and re-suspended in fresh media before transferring into the 96-well plate for 36 hour
incubation at 37 ºC and 5% CO2. The prostate (PC-3) and breast (MCF-7) cancer cells were
cultured in the 25 cm3 flask with the growth media to form a monolayer on the flask surface. The
cells were checked for conformation (Trypan blue dye exclusion test) for minimum counts of
≥3000. They are detached from the flask surface by adding Trypsin-EDTA and re-suspended in
respective fresh media. The four types of cancer cells were transferred to separate 96-well plates
(200 µL/well) for a 36 hour incubation at 37 ºC and 5% CO2. The nine soybean peptide fractions
dissolved in water (800ug/mL) were added to the wells with the cancer cells. A column of wells
were treated with saline (negative control) while Genistein (200 µg/mL) was used as positive
control for comparison of growth inhibition. The cancer cells were incubated for 18-36 hours
while being observed for cell death due to the test compounds. The MTS dye was added to
determine cell survival and termination was observed by the formation of colored formazan
product. The 96-well plate was read at 490 nm in a Microplate Reader (Bio-Rad Inc., Hercules,
CA, USA) and the percent inhibition was determined based on the absorbance value (Rayaprolu
et al., 2013).
Quantitative Evaluation of Dose Response by Trypan Blue Dye Exclusion Assay.
The cancer cell growth inhibition based on dosage of GI resistant soy peptide fractions
was established based on the Trypan Blue dye exclusion assay. This is conducted for the GIresistant peptide fractions that showed highest cytotoxicity against the four cancer cells tested.
For trypan blue staining, 500 µL of cells from each cancer cell culture were aseptically
transferred to a 24 well plate and incubated for 72 hours. The peptide fractions with
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concentrations ranging from 200 to 1000 µg/mL were added to the wells along with media and
incubated for 48 to 60 hours at 37 ºC and 5% Co2. The wells were treated with 0.4% (w/v)
Trypan blue solution prepared in 0.81% NaCl and 0.06% (w/v) dibasic potassium phosphate.
Cell counts were determined using a dual-chamber hemocytometer and a phase contrast
microscope. Numbers of viable cells were recorded based on the stain retention.
Calculations and Statistics.
All tests were conducted in triplicate to minimize experimental error and were repeated
for reproducibility. The JMP 12.0 statistical software (SAS institute, Cary, NC) was used for all
data analyses.

Results and Discussion
Protein hydrolysate preparation
Protein isolates prepared from the meal (defatted flour) of the R95-1705, S03-543CR and
N98-4445A soybean lines had a purity of 90% or higher due to the effective alkaline extraction
procedure (Rayaprolu et al., 2013). Alcalase, a food grade enzyme, was sued to produce protein
hydrolysates from the isolates. The degree of hydrolysis was used as the response variable in the
modelling of enzymatic hydrolysis and varying molecular sized protein fragments were collected
(Nielsen et al., 2001). This was in congruence with the premise of this study which is to
determine the bioactivities of peptides with various lengths and amino acid sequences. The
simulated GI resistance test demonstrated that the peptides are resistant to digestion in the GI
tract and will remain bioactive without undergoing any degradation when consumed. The protein
content of the GI-resistant fractions from the three soybean lines ranged between 85 and 88%
purity.
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Anti-proliferative activity of GI-resistant peptide fractions against cancer cell lines
Previous studies have shown that protein products are effective against various cancers
(Bylund et al., 2000, Badger et al., 2005). All the 4 cancer cell types had counts ranging from
3000 to 5000 (>70% confluence) during the growth phase in the culture flasks. The
morphological confirmation of the blood, prostate and breast cancer cells during initial
proliferation showed no shrinkage or nuclear blebbing, which was essential for the experiment.
The results showed that 68% of CCRF-CEM blood cancer cells were inhibited by the
10-50kDa fraction from the N98-4445A soybean line (Figure 6.1) which was the highest among
all fractions tested. The 5-10kDa fraction from the same soybean line showed 52% cytotoxicity
which was significantly different from the 5-10kDa fraction of S03-543CR (41% inhibition).
On the Kasumi-3 blood cancer cell line <5kDa (52%) and 10-50kDa (49%) fractions from the
N98-4445A soybean line and 5-10kDa (55%) fraction from S03-543CR inhibited the cell
growth with no statistically significant difference (P<0.05) amongst them (Figure 6.3).
However, the 5-10kDa of S03-543CR had the highest inhibition among all the fractions. The 510kDa fractions from S03-543CR and R95-1705 soybean lines showed 41 (CCRF-CEM) and
37 (Kasumi-3) percent inhibition respectively which was the only other significant reduction
observed during the MTS assay on the two blood cancer cell lines (Figures 6.1 and 6.2).
The 5-10kDa fraction from S03-543CR soybean line showed 63% inhibition against the
PC-3 prostate cancer cells, while the 10-50kDa fraction from N98-4445A soybean line inhibited
58% of the cells (Figure 6.3). Similar sized fraction (5-10kDa) obtained from R95-1705
soybean line also showed 38% inhibition of the PC-3 cells but there was significantly lower.
The other fractions that were tested did not demonstrate any activity against the prostate cancer

123

cells. This is the first study that revealed the efficiency of GI resistant fractions from a seed
protein in inhibiting in vitro prostate cancer cell proliferation.
The MCF-7 breast cancer cells were used as a model system for testing anti proliferative
activity and biochemical pathways by various researchers (Doyle et al., 1998, Kannan et al.,
2009, Chen et al., 2012 and Li et al., 2014a). The 5-10kDa fraction from the R95-1705 soybean
line showed a significantly high activity among all the fractions with 63% inhibition of MCF-7
cells (Figure 6.4). This was not statistically different (P value <0.05) from the positive control.
This result has a major impact on future studies involving anticancer agents from plant sources
since R95-1705 is a non-transgenic (non-GMO) soybean line. The <5kDa and 10-50kDa from
the R95-1705 soy line also inhibited the MCF-7 cells and the activity was significant in
comparison to the other fractions. The three fractions from the S03-543CR high oleic acid line
showed extremely poor activity against the breast cancer cells while the fractions from N984445A soybean line showed 18-30% inhibition of the MCF-7 cells.
The normal peripheral blood cells were required to be cultured immediately after
thawing the procured frozen stocks and showed 2 x 103 counts when cultured with the growth
medium in the 96-well plates. The toxicity test of the peptide fractions on normal human blood
cell line showed no significant effect (< 2-5%) in comparison to Genistein that showed
inhibition of normal blood cells by 11%. These results demonstrate that the peptide fractions
can reduce the cancer cell growth without affecting the neighboring normal human cells. A
summary of effective cancer cell inhibitory activity demonstrated by the various peptide
fractions is given in Table 6.1. Further purification of the fractions into pure peptides may
provide enhanced anticancer effect. Other researchers have demonstrated an effective anticancer
activity of single peptides against breast cancer (Kannan et al., 2009 and Li et al., 2014a,
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2014b). These results have demonstrated the immense potential of peptide fractions and
peptides in reducing in vitro breast cancer cell proliferation. Continuation of this research with
clinical trials may provide potential drug-free or supplemental therapeutic solutions in treating
cancers.
Dose response study based on Trypan blue dye exclusion method
The Trypan blue dye exclusion test has been used for numerically quantifying the cell
counts. This test provided the cell counts against the dose response of the specific fractions that
showed highest inhibitory activity based on MTS colorimetric method. The established cell
counts based on Trypan blue assay provided a quantitative scrutiny of the effectiveness of
peptide fractions against the cancer cells. The results from the assay correspond to the cell
survival/viability percentage calculated based on the counts in comparison to a known positive
control, Genistein. Among the fractions, the 5-10kDa fraction from S03-543CR soybean line
showed the best growth inhibition of both prostate and Kasumi-3 blood cancer cell lines (Figure
6.5). The dose response showed significant increase in activity at >600 µg/mL which was
observed on PC-3, CCRF-CEM and MCF-7 cell lines with approximately 50% reduction in cell
survival. The 5-10kDa fraction from the S03-543CR soy line showed the highest reduction at
1000µg/mL on PC-3 cell counts which was not significantly different in comparison to Genistein
(P value <0.05). Although the cell survival % reduced to less than 20% in the blood cancer cell
lines (CCRF-CEM and Kasumi-3) the positive control had the significantly higher inhibition. On
the MCF-7 breast cancer cell line, the 5-10kDa fraction showed a significant reduction in cell
survival at the ≥800µg/mL dose. The minimum effective concentration (EC50) for the 5-10kDa
(S03-543CR) fraction against PC-3 prostate cancer cells was found to be 608 µg/mL. The 1050kDa fraction from N98-4445A against CCRF-CEM blood cancer cells was 678 µg/mL while
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the 5-10kDa fraction of S03-543CR had an EC50 value of 611 µg/mL on the Kaumi-3 cells. On
the MCF-7 breast cancer cell line, the 5-10kDa fraction from R95-1705 showed a significant
reduction in cell survival (10%) at a dosage of 1000 µg/mL dose with an EC50 of 654 µg/mL.

Conclusion
Enzymatic hydrolysis (with and without protein extraction) has been proven to be a
promising approach to obtain peptides from protein sources that are considered a bio-waste
(Kannan et al., 2008, 2009 and Rayaprolu et al., 2013). This study is the first of its kind to report
utilization of soybean meal to obtain bioactive peptides against multiple-site cancer cells. Soy
peptide fractions obtained after proteolytic digestion and tested for GI resistance showed potent
anticancer activity against human blood, breast and prostate cells. These GI resistant peptides are
suitable for use in food product applications due to potential bio-availability when consumed.
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Figure 6.1. Bioactivity of peptide hydrolysates prepared from two high oleic (N98-4445A
and S03-543CR) and one high protein (R95-1705) soybean lines against CCRF-CEM
human blood cancer cells. Positive control: Genistein 200 µg/ml, Negative control: Saline. The
bars represent % inhibition values expressed as means ± standard deviation (of triplicates) and
those not connected by same letter are significantly different (P <0.05).
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Figure 6.2. Bioactivity of peptide hydrolysates prepared from two high oleic (N98-4445A
and S03-543CR) and one high protein (R95-1705) soybean lines against Kasumi-3 human
blood cancer cells. Positive control: Genistein 200 µg/ml, Negative control: Saline. The bars
represent % inhibition values expressed as means ± standard deviation (of triplicates) and those
not connected by same letter are significantly different (P <0.05).
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Figure 6.3. Bioactivity of peptide hydrolysates prepared from two high oleic (N98-4445A
and S03-543CR) and one high protein (R95-1705) soybean lines against PC-3 human
prostate cancer cells. Positive control: Genistein 200 µg/ml, Negative control: Saline. The bars
represent % inhibition values expressed as means ± standard deviation (of triplicates) and those
not connected by same letter are significantly different (P <0.05).
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Figure 6.4. Bioactivity of peptide hydrolysates prepared from two high oleic (N98-4445A
and S03-543CR) and one high protein (R95-1705) soybean lines against MCF-7 human
breast cancer cells. Positive control: Genistein 200 µg/ml, Negative control: Saline. The bars
represent % inhibition values expressed as means ± standard deviation (of triplicates) and those
not connected by same letter are significantly different (P <0.05).
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Figure 6.5. Dose response study of GI resistant fractions with highest anticancer activity
based on Trypan blue dye exclusion assay. Positive control: Genistein 200µg/ml. PC-3:
Prostate cancer; CCRF_CEM: Blood cancer; Kasumi-3: Blood cancer; and MCF-7: Breast
cancer. Soybean lines are designated as: S03 = S03-543CR, N98 = N98-4445A and R95 = R951705. Values expressed as means ± standard deviation (of triplicates) and those not connected by
same letter for each cancer type and protein hydrolysate combination are significantly different
(P <0.05).
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Table 6.1. Summary of anticancer activity of selected peptide fractions prepared from
three soybean lines against human cancer cells.
Type of Cancer cell
Anticancer activity (% inhibition) of GI-resistant peptide fractions
(N98) 10-50kDa
(S03) 5-10kDa
(R95) 5-10kDa
Blood, CCRF-CEM

68.0±0.5a

41.0±0.7b

23.3±0.9c

Blood, Kasumi-3

49.6±1.9b

55.3±3.3a

37.2±2.7c

Breast, MCF-7

33.1±1.6b

10.4±3.9c

64.9±3.9a

Prostate, PC-3

57.9±1.7b

63.2±5.1a

39.0±6.8c

The values presented are means ± standard deviations from triplicate analysis. The values not
connected by same letters in each horizontal row are significantly different (P <0.05).
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CHAPTER 7
Purification and characterization of single peptides with anticancer activities

Abstract
The objective of this research was to identify and purify peptides from the protein hydrolysate
fraction prepared from soybean line that previously showed significant activity against human
cancer cell lines. Protein isolate from a high oleic acid soybean line N98-4445A was used to
prepare the peptide pools. The 10-50kDa molecular size cut-off fractions showed the highest
activity which were purified using peptide specific affinity chromatography column. Reverse
phase HPLC identified three peptides from the fractions. These three individual peptides were
tested for anti-proliferative activity against HCT-116 colon cancer cell line, CCRF-CEM blood
cancer cell line and HepG-2 liver cancer cell line using (3-(4, 5-dimethylthiazole-2-yl)-5-(3carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) cell titer assay. Enhanced
colon cancer cell inhibition activity of 80% was observed after testing a pure peptide which also
demonstrated a time-response of 96 hour after incubation based on Trypan blue dye exclusion
study. This single peptide with highest activity had a molecular size of 18kDa with 158 amino
acid residues. The impact of this study lies in deriving a pure single peptide with antiproliferative activity on human colon and blood cancer cells.
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Introduction
Physical and chemical treatments, including enzymatic catalysis of food proteins are
conducted to derive bioactive peptides. But, chemical treatments may contribute to inactive
peptides by preventing them from being released from the parent protein – as resistant peptide
bonds can be generated (Rutherford-Markwick and Moughan, 2005). However, enzymatic
hydrolysis has been proven to be the most effective method to derive bioactive peptides from
protein sources (Seppo et al., 2003, Korhonen and Pihlanto, 2006, Kannan et al., 2008, 2009 and
2012, Rayaprolu et al., 2013 and 2015). Controlled enzymatic hydrolysis can generate peptides
that can elicit bioactivity including anti-proliferative action against cancer cell lines. Studies
have shown that enzyme catalysis provides peptides from various food sources that can act as
physiological biomolecules (Yoo et al., 1997, Ng et al., 2003, Korhonen and Pihlanto, 2003,
Ohba et al., 2004, Gibbs et al., 2004, Kannan et al., 2010, Li et al., 2014). Identifying the peptide
structure and the amino acid sequence can provide further details into its functional properties
and its synthesis for pharmaceutical and nutraceutical applications.
Proper analytical separation and purification techniques can identify peptides that are
important biological modulators. Various analytical separation techniques include
microflitration, ultrafiltration, nanofiltration, and reverse osmosis. Deeslie and Cherian (2006)
studied soy protein hydrolysate fractionation using ultrafiltration membranes using membrane
pore sizes that were specific to the molecular size distribution of the peptides with functional
properties. Reverse phase high performance liquid chromatography (RP-HPLC) with ionexchange or size exclusion chromatography has been widely used for efficient purification of the
peptides (Le´onil et al, 2000) prepared using catalysis with Alcalase and flavourzyme (Prakash et
al., 2002). A peptide inhibiting obesity was isolated and purified from soybean protein
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hydrolysate using a systematic separation with ultrafiltration, gel filtration chromatography, and
reverse-phase HPLC by previous researchers (Kim et al., 2007). These methods provided
evidence to distinguish and select the appropriate search results for peptide purification.
For a comprehensive characterization of complex mixtures of peptide, chromatographic
analytical methods were used to better separate peptides prior to mass spectrometric analysis
(Léonil et al., 2000). These methods can be used in succession to achieve a very high degree of
resolution. The most effective way to identify and quantify proteins and their modifications by
mass spectrometry (MS) is to analyze enzyme (trypsin) digests of the proteins of interest. Liquid
chromatography (LC) coupled with mass spectrometry is by far the most informative technique
for determining the purity of protein/peptide samples (Ono et al., 2006, Peng et al., 2003) It is a
technique of analytical chemistry to identify the molecular mass of isolated individual peptides
present in a sample by measuring the mass-to-charge ratio and abundance of gas-phase ions. The
mass spectrum is a plot of the ion signal as a function of the mass-to-charge ratio which provides
the number of ionic components present and indicates the length of the proteins/peptides
(Desiderio, 1990, Sunner et al., 1995). Database search when used in conjunction with MS offers
increasingly enhanced information in the characterization of peptides. Of the ionization modes,
Matrix assisted laser desorption ionization (MALDI) has made it possible to not only determine
the accurate mass of peptides obtained in a hydrolysate of food proteins but also is able to
identify the purity of a pure protein or peptide, determine its fragmenting patterns and also
determine the de novo sequence of the amino acids.
Our previous studies have shown that a 10-50kDa fraction obtained from a high
oleic acid soybean line has anti-proliferative activity against blood (CCRF-CEM), colon (Caco-2
and HCT-116) and liver (HepG-2) cancer cell lines. Hence, the objective of this study was to
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separate single pure peptides from a pool using RP-HPLC and size exclusion, and test them on
colon, blood and liver cancer cell lines for investigation of cell proliferation inhibitory
properties. Further characterization and amino acid sequence of the single peptide, that showed
highest cancer cell cytotoxicity, was determined by mass spectrometry.

Materials and methods
Purification of hydrolysates by HPLC to separate single peptides
Soy protein isolate was prepared by alkaline hydrolysis (pH 9.5) from the seeds of N984445A soybean line. It was hydrolyzed using Alcalase enzyme, tested for simulated gastrointestinal juice resistance and fractionated using ultrafiltration columns with definite molecular
size cut-offs (Rayaprolu et al., 2013). The 10-50kDa peptide fractions so derived showed highest
anti-proliferation activity against colon, liver and blood cancer cells. This fraction was selected
for further purification using a Supelco Bio Wide pore C-18 semi-preparative chromatography
column from Sigma Aldrich (St. Louis, MO) connected to an HP 1050 series HPLC system from
Agilent Technologies (Santa Clara, CA), to identify and separate individual peptides.
A two solvent reverse phase HPLC analysis of the peptide fractions was conducted.
Solvent A: 0.1 % Trifluoro Acetic acid in 10mM Phosphate buffer at pH 7.3 and solvent B: 50 %
Acetonitrile in water with 0.1 % Trifluoro Acetic acid in a linear gradient for a 90 minute run.
The flow rate was maintained at 1 mL/min with the solvent A: 50 % to 0 % for 50 min and
solvent B: 0 to 100 % for 90 min.
Size exclusion chromatography of peptides
Analytical grade Sephadex G-15 hydrophilic resin was purchased from Sigma Aldrich
(St. Louis, MO) and packed into a glass column and equilibrated with Millipore water. The
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column was connected to a semi-preparative HPLC system with one pump running in a binary
phase. A 1mL sample of 10-50kDa peptide hydrolysate (~0.5 mg/mL protein concentration) was
loaded onto the column at 1 mL/min flow rate. Five bed volumes of degassed, double filtered
water were used to wash the peptide fractions as they pass through the resin beads in the stacked
column. The individual peptides from the fraction were eluted using Millipore water with a run
time of 85 minutes. The eluates were collected, concentrated in the Spin-X concentrator from
Corning life sciences (Corning, NY), lyophilized and stored at 4 °C until used for cancer cell
proliferation inhibition activity. The bioactivity against cancer cells by the pure peptides
obtained after ion-exchange was determined using the cell proliferation inhibition assay.
Determination of anti-proliferation activity against cancer cells by the pure peptides.
The [3-(4,5- dimethyl thiazole-2-yl)]-2,5-diphenyl tetrazolium bromide (MTS) based cell
titer assay was used to determine the effect of soybean peptide fractions on the cytotoxicity
against cancer cells.. The cancer cell lines CCRF-CEM (blood), HCT-116 (colon) and HepG-2
(liver) were cultured in the required growth media in in the 25 cm3 flasks. The blood cancer cells
remained suspended over the length of the culture and did not attach to the well surface. Hence,
fresh growth media was added every 72 hours by separating the cells using centrifugation (150 g
for 5 min). The colon and liver cancer cell lines were detached from the flask surface by adding
Trypsin-EDTA and re-suspended in respective fresh media. All cell lines were incubated at 37 ºC
and 5% CO2 for 72 hours and checked for confluence using Trypan blue dye exclusion assay
(Kannan et al., 2008). After ensuring a minimum count of ≥3000 they were transferred into
separate 96-well plates. The three peptides purified from the 10-50kDa fraction obtained from
N98-4445A soybean line were added (dissolved in water) to the wells with the cancer cells.
Saline (1%) and genistein (200µg/mL) were used as controls for comparison of growth
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inhibition. The incubated 96 well plates were observed periodically for cell death due to the test
compounds. The MTS dye was added to the wells to determine mitochondrial activity and
termination of the assay was observed due to the formation of colored formazan product.
Absorbance of the well constituents were measured at 490 nm using a micro Epoch plate reader
from Biotek (Winooski, VT) and the percent inhibition was determined based on the absorbance
value.
Time response study of most effective peptide on colon cancer cells
The Trypan blue dye exclusion assay was used to determine the time response of the
most effective peptide for cytotoxicity against the blood and colon cancer cells over the
incubation period (Strober, 2001). The cells were cultured in 25 cm3 flasks for ≥70% confluence
and transferred to a 24-well plate. The peptide (700 µg/mL) was added to the cells and incubated
at 37 ºC and 5% CO2 for 96 hours. Trypan blue dye was added to the wells at periodic intervals
to determine the surviving cell counts using the hemocytometer. Cell survival was determined at
24, 48, 72 and 96 hours of incubation and survival percentage was calculated. Cell counts from
the control samples, saline solution and genistein (200 µg/mL), were used for comparison.
Determination of the peptide mass and sequence using Mass Spectrometry
Sodium Dodecyl Sulfate-Poly Acrylamide Gel Electrophoresis (SDS-PAGE) was used to
identify the single peptides present in the fraction and to ascertain the approximate molecular
size of the single peptide with highest activity. Serum albumin (70kDa) was used as a molecular
standard. The peptide was separated from the gel matrix and sliced to small pieces before
washing, to remove the stain, using 25mM ammonium bicarbonate solution in acetonitrile. The
gel pieces with the peptide were washed in acetonitrile and dried before adding trypsin for
digestion. The tryptic digests were analyzed for the sequences of amino acid residues using
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liquid chromatography coupled with mass spectrometry (LC-MS) to separate the tryptic fractions
and mass spectrometry (MS/MS) system to identify the amino acid sequences with the highest
score. The samples were analyzed using spectrometer for emergence of peaks corresponding to
single peptide based on their mass ratios (Grimm et al., 1998).
The molecular mass of the peptide with highest activity identified and collected after
chromatography studies was confirmed using the matrix assisted laser desorption ionization &
time-of-flight (MALDI-TOF) Bruker Daltonics GMBH (Bremen, Germany) at the State Wide
Mass Spectrometry Facility, University of Arkansas. All other HPLC grade chemicals were
purchased from Sigma (St. Louis, MO).
Statistical analysis
All tests were conducted in triplicate to minimize experimental error and were repeated
for reproducibility. The JMP 9.0 statistical software (SAS institute, Cary, NC) was used for all
data analyses.

Results
Purification of the peptide fraction with highest activity to obtain single pure peptides
Based on the previous results (Rayaprolu et al., 2013) from the cytotoxicity assay on the
cancer cell lines, the 10-50 kDa peptide fraction with highest activity (70-73%) obtained from
N98-4445A soybean line was selected for further purification. HPLC analysis of the 10-50kDa
fractions revealed three peaks at varying elution times. The Figure 1 shows the isolation of three
single peptides from the 10-50 kDa peptide fractions from N98-4445A soybean line. The semipreparative HPLC was used with an affinity column to collect the peptides separately based on
their elution times. The retention times for the three peptides were found to be 58, 67 and 79
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minutes. The chromatogram identified the three peaks at distinct retention times. The three
peptides were separately collected using the size exclusion column, concentrated, lyophilized
and stored at 4 °C.
Anti-proliferative activity of pure peptides against blood, colon and liver cancer cell lines.
The single peptides collected from the chromatographic separation were tested for
inhibition activity against the blood, colon and liver cancer cells. They were designated as E58,
E67 and E79 based on their retention times during the chromatographic elution. The MTS assay
determined the anticancer activity of the pure peptides, E58, E67 and E79, on the blood, colon
and liver cancer cells (Figure 2). The test showed that the peptide E67 had significant antiproliferative activity against colon and blood cancer cells with 74 and 80% inhibition
respectively. The positive control, genistein, had higher comparatively inhibition of both the
cancer cells. The E79 peptide showed highest activity of 75% inhibition against the liver cancer
cells.
Although the peptide did not show a 100% kill on the colon cancer cells, it is significant
to note its enhanced effect against cancer cell proliferation of 80% which can support its role in
alternative cancer therapies. Previous studies have noted similar observation when a pure
peptide, produced from rice bran and sequenced for amino acids, was tested for apoptotic
molecular targets in MCF-7 breast cancer cells (Li et al., 2014a). The pure peptides
demonstrated significantly higher anti-proliferation activity on the three cancer cells in
comparison to that of the peptide fractions (Rayaprolu et al., 2013) from which they were
purified, which was observed in our previous research. Based on the results the peptide E67 with
the highest activity (80%) was further evaluated for cancer cell survival response using the
Trypan blue dye exclusion assay to determine the impact of incubation time.
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Time response study of the most effective peptide against human cancer cells.
The cell counts from the Trypan blue dye exclusion assay were used to quantify the effect
of the peptide for reduction in cancer cell growth over time. The time response study showed that
the peptide E67 reduced the survival of colon cancer cells to ~11% after 96 hours of incubation
(Figure 3). However, the peptide reduced the CCRF-CEM blood cancer cell population by
approximately 19% by the end of 96 hour incubation period. Similar observation was made by
previous studies using single peptides that reduced cancer cell proliferation (Kannan, 2009). It
was observed that the positive control genistein caused rapid cell death by 48 hour incubation
and reduced the cancer cell population to almost 0% by 96 hours. It is also noted that the cell
survival was reduced by >50% by 72 hours in both blood and colon cancer cells.
Determination of molecular size and characterization of the peptide with most significant
anti-proliferation activity on human cancer cells.
The SDS-PAGE analysis showed the single peptides in the 10-50kDa fraction (Figure
7.4.). The approximate molecular mass of the most effective peptide ranged between 15-20kDa
in the gel electrophoresis which was confirmed by the MALDI-TOF analysis to be 18kDa. The
MS/MS spectra of peptides contained fragment ions, which result from single or multiple
cleavages of peptide backbone bonds. The mass spectrometry (MALDI-TOF-MS) analysis
located an intact peptide based on the single protonated molecular ions (M+H+) which indicated
the presence of the pure peptide that showed highest bioactivity in previous studies (Wysocki et
al., 2005, Tamvakopoulos, 2007, Murao et al., 2007, Kannan et al., 2010).
Characterizing a pure peptide and identifying its structural components confirms the
peptide to its identity, and enhanced bioactivity. Absence of knowledge on the sequence of a
peptide can explain the extraction of sequence information from MS/MS spectra or fragment ion
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spectra through de novo sequencing. The tryptic hydrolysates with arginine or lysine residues at
the N terminal when analyzed with MS revealed the peptide sequence which were matched with
the soybean proteome for confirmation. The number of amino acids were identified from the C
terminus end (Sequence) and a match with the National Center for Biotechnology Information
(NCBI) database for the N-terminal amino acids showed a high prediction (>95%) with 158
amino acids in the peptide sequence. This peptide is recognized as the 2S albumin precursor
from the soybean proteome provided in the NCBI database. The peptide sequencing with LC-MS
and MS/MS analysis shown in Figure 5 (a, b and c) identified 158 amino acid residues in the
sequence given as: MTKFTILLISLLFCIAHTCSASKWQHQQDSCRKQLQGVNLTPCEKHIM
EKIQGRGDDDDDDDDDNHILRTMRGRINYIRRNEGKDEDEEEEGHMQKCCTEMSELRS
PKCQCKALQKIMENQSEELEEKQKKKMEKELINLATMCRFGPMIQCDLSSDD-n.
Presence of multiple lysine, arginine and cysteine amino residues in the sequence
potentially contributed to the anti-proliferation activity on cancer cells which is in congruence
with previous research (Usui et al., 2004, Cooper et al., 2011, Nakase et al., 2012). Medium
sized (<50kDa) bioactive peptides as have been isolated and purified from various cereals and
legumes (Korhonen and Pihlanto, 2003). Hence, this advocates and confirms the production of a
cancer anti-proliferative peptide from soybean protein isolate after enzymatic hydrolysis.

Conclusion
Soybean is a good source to derive a pure bioactive peptide that showed 80% inhibition
human colon and blood cancer cells in comparison to the 10-50kDa peptide fraction (73%) from
which it was purified. Purification of the peptide fraction resulted in a potent single peptide with
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highest anti-proliferative activity that can be tested against other prominent cancer cells. This
research has potential implications in inexpensive and alternative cancer therapy.
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Figure 7.1. HPLC analysis of the 10-50 kDa peptide hyrdolysate from N98-445A with three
eluents identified based on time and peak area. Acetonitrile (50%) and water (100%) with
Trifluoro Acetic acid (0.1%) was used as the solvent system to purify the peptides. Single peaks
were depicted by the arrow heads.
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Figure 7.2. Single peptides purified from 10-50kDa fraction of N98-4445A soybean line
show enhanced anti-proliferative activities against human blood, colon, and liver cancer
cell lines. Bars represent means ± standard deviations and those not connected with same letter
are significantly different (P <0.05). The dosage of the peptides applied was 700 µg/mL while
1% saline solution was used as negative control (Neg Ctrl).
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Figure 7.3. Confirmation of cancer cell survival reduction by the E67 peptide tested on
HCT-116 colon cancer and CCRF-CEM blood cancer cells using Trypan blue dye
exclusion assay. Bars presented are means ± standard deviation and those not connected by
same letter for each cancer type are significantly different (P <0.05). Genistein (200 µg/mL) was
used as positive control (Pos Ctrl) for comparison which was shown for each cancer type
separately.
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Figure 7.4 (a, b). Identification of the single pure peptide with significantly high activity
against cancer cells using SDS-PAGE analysis. The arrow shows the anticancer peptide
isolated from the N98-4445A soybean line. Serum albumin was used as a standard protein.
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[145, 157]
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[116, 127]

CCTEMSELR
[96, 104]

IMENQSEELEEK.Q
[116, 127]

CCTEMSELR [96, 104]

(Fig. 7.5a)
Amino acid sequence:
MTKFTILLISLLFCIAHTCSASKWQHQQDSCRKQLQGVNL
TPCEKHIMEKIQGRGDDDDDDDDDNHILRTMRGRINYIRR
NEGKDEDEEEEGHMQKCCTEMSELRSPKCQCKALQKIME
NQSEELEEKQKKKMEKELINLATMCRFGPMIQCDLSSDD

(Fig.
7.5c)
(Fig.
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(Fig.
(Fig.7.5d)
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Figure 7.5 (a, b, c and d). Profile of the pure peptide sequence identified using LC-MS and MS/MS. Figure 7.5a shows the LC-MS
analysis of the tryptic fractions in a sequence while the figures 7.5b - 7.5d show the MS/MS profiles of the three tryptic fractions
which are used to identify the sequence of the peptide from the soybean proteome.

CONCLUSION
The basis for this research was utilization of an inexpensive co-product of soybean oil
industry in developing novel gastrointestinal environment resistant biologically active peptides.
These peptides showed effective inhibition of angiotensin-I converting enzyme (ACE-I), which
regulates hypertension, and multiple-site cancer cell anti-proliferation activity. Higher protein
content is a criterion for choosing soybeans as a good source for generating innovative bioactive
peptides against chronic diseases. This is in congruence with FDA’s recommendation that adding
25 g of soy protein in the diet can reduce risk of heart-related as well as other diseases. Currently
soybeans with higher content (≥85%) of oleic acid are becoming popular in the U. S. which can
also be excellent source of proteins. This research has demonstrated that alkaline method of
protein separation from the meal, hydrolysis using food-grade enzyme, evaluation of resistance
to gastrointestinal (GI) juices and fractionation using ultrafiltration was favorable in deriving
peptides that were GI resistant. Testing the potency of the GI resistant peptides by challenging
them for activities including anti-ACE-I and multiple-site anti-proliferation of cancer cells is the
characteristic aspect of this research.
Medium molecular weight 10-50kDa fractions and a pure peptide derived from the
peptide pool demonstrated significant bioactive properties. This single peptide containing 158
amino acid residues in the sequence was characterized using mass spectrometry and established
proteomic tools. This information on its structural components can be used for synthesizing the
peptide for applications as a health promoting food ingredient, nutraceutical or for medicinal use.
This can initiate future research in the direction of using protein products as components in
alternative therapies for chronic human diseases.
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